{"file_path": "/Users/sz904/Desktop/11711/LTI_Neural_Navigator/data/2024-02-26/chunk_paper_txt/Rita_Singh_A_Gene-Based_Algorithm_for_Identifying_Factors_That_May_Affect_a_Speaker\u2019s_Voice_chunk_11.txt", "num_qa_pairs": 10, "qa_list": [{"question": " What information is provided in the second column of the table for the syndrome?,answer: The second column lists the corresponding speech characteristics, with references.", "ref_chunk": "in the voicechains found for the syndrome are shown in bold font. Second column: The second column in this table lists the corresponding speech characteristics, with references. Where no reference is cited, the information is found in the OMIM record for the syndrome (where possible, OMIM references are used for brevity). Table A1. Chainlink genes for level-1 and level-2 voice chain ensembles for 76 chromosomal mi- crodeletion syndromes. Each chain forms a link from the gene shown to the ACC biological pathway of FOXP2 and has been automatically derived. The total number of pathways that each gene in\ufb02u- ences independently is shown as a subscript to its name. Observed phenotypic effects on speech are given in the last column. When references are not cited, the information re\ufb02ects that in the OMIM records for the syndrome. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 1 deletions 1p36 OMIM: 607872; Cytogenetic location: 1p36; Genomic coordinates (GRCh38): 1:23,600,000\u2013 27,600,000 Names: Chromosome 1p36 deletion sydrome; monosomy 1p36 syndrome {VN1} ARID1A10 {VN2}: PIK3CD168 MTOR146 GNB1140 CDC42140 CASP9108 RPS6KA193 PRKCZ75 CNKSR157 SFN55 DVL148 (216 more . . .) SSU721 RBP71 PLEKHN11 PLEKHM21 PEX101 NBL11 MTCO3P121 MMP23B1 MMP23A1 HSPB71 HMGN21 GPR31 EXOSC101 DISP31 CROCCP21 CAMTA11 AHDC11 ACAP31 1q21.1\u2013q21.2 OMIM: 612474/274000, Cytogenetic location: 1q21.1 Genomic coordinates (GRCh38): 1:143,200,000\u2013147,500,000 Names: Thrombocytopenia with absent radius (TAR) syndrome (OMIM 274000) {VN2}: H4C1467 H4C1566 H2BC2163 PRKAB257 H3C1556 H3C1456 H3C1356 H2AC2053 H2AC1953 H2AC1853 (31 more . . .) 1q41\u2013q42 OMIM: 612530; Cytogenetic location: 1q41\u2013q42 Genomic coordinates (GRCh38): 1:214,400,000\u2013 236,400,000 Names: Chromosome 1q41\u2013q42 deletion syndrome; holoprosencephaly 10; HPE10 {VN2}: NUP13388 H2BU163 TGFB262 DUSP1054 H3-3A50 WNT3A47 ARF146 PARP141 MIR362038 PSEN236 (50 more . . .) DISP12 MIR2151 MIR194-11 DNAH141 CDC42BPA1 1q43\u2013q44 OMIM: 612337 Names: Mental retardation, autosomal dominant 22; MRD22; chromosome 1q43\u2013q44 deletion syndrome (included); chromosome 1qter deletion syndrome (included) {VN2}: AKT3169 RYR274 ACTN269 CHRM342 MTR38 FH31 ADSS230 EXO126 RGS716 KMO15 (68 more . . .) FMN21 (Implicated Genes from Microarray Studies) (Multiple incl. RERE, SPEN) \u2020\u2021 (Multiple incl. RBM8A \u2020\u2021, GJAS \u2020) (Multiple incl. DISP1, HPE10, LEFTY1, LEFTY2, WDR26, TSEN2, BPNT1) \u2020\u2021 (AKT3, ZBTB18) \u2021 Reported Effects on Speech Delayed [9] or absent speech Delayed [10] or Impaired [11] speech Apraxia [12] Delayed, impaired, or absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 2 deletions 2p16.1\u2013p15 OMIM: 612513; Cytogenetic location: 2p16.1\u2013p15 Genomic coordinates (GRCh38): 2:54,700,000\u2013 63,900,000 Names: Chromosome 2p16.1\u2013p15 deletion syndrome {VN2}: RPS27A293 XPO156 UGP233 MDH127 REL23 CCT414 RTN413 B3GNT212 VRK210 USP347 (7 more . . .) OTX11 CCDC88A1 2p21 OMIM: 606407; Cytogenetic location: 2p21 Genomic coordinates (GRCh38): 2:41,500,000\u2013 47,500,000 Names: Hypotonia\u2013cystinuria syndrome; cystinuria with mitochondrial disease; homozygous 2p21 deletion syndrome {VN2}: CALM2234 PRKCE73 SLC3A136 HAAO22 ATP6V1E219 ABCG518 MSH217 ABCG817 EPAS116 COX7A2L15 (14 more . . .) SIX31 EML41 2q23.1 OMIM: 156200 Names: Mental retardation, autosomal dominant 1; MRD1; chromosome 2q23.1 deletion syndrome {VN2}: ORC429 KIF5C2 2q32\u2013q33 (SATB2) \u2021(HOXD cluster and regulatory elements, COL3A1 COL5A2, GTF3C3, CASP8, CASP10) \u2021\u2021 OMIM: 612313 Names: Glass syndrome; GLASS; chromosome 2q32\u2013q33 deletion syndrome; SATB2-associated syndrome {VN2}: CREB1203 STAT1130 CASP8103 NUP3579 ITGAV64 CD2860 SUMO152 AOX150 FZD543 FZD737 (52 more . . .) TMEFF21 KLF71 HSPE11 DUSP191 DNAH71 (HDAC4) \u2021 2q37.3 OMIM: 600430 (2q37); Cytogenetic location: 2q37 Genomic coordinates (GRCh38): 2:236,400,000\u2013 242,193,529 Names: Chromosome 2q37 deletion syndrome, brachydactyly\u2013intellectual disability syndrome; Albright hereditary osteodystrophy-like syndrome Type 3 {VN2}: HDAC433 GPC127 AGXT25 COL6A319 ACKR314 NEU413 NDUFA1012 PRLH11 PER211 DTYMK11 (28 more . . .) TWIST21 ILKAP1 Chromosome 3 deletions 3p13 OMIM: 613670 Names: Mental retardation with language impairment with or without autistic features {VN2}: MITF19 PROK28 PPP4R25 GPR275 EIF4E35 FOXP13 GXYLT22 RYBP1 3q13.31 OMIM: 615433; Cytogenetic location: 3q13.31 Genomic coordinates (GRCh38): 3:113,700,000\u2013 117,600,000 Names: Chromosome 3q13.31 deletion syndrome {VN2}: DRD322 ATP6V1A22 GAP436 QTRT23 LSAMP3 3q29 OMIM: 609425; Cytogenetic location: 3q29 Genomic coordinates (GRCh38): 3:192,600,000\u2013 198,295,559 Names: Chromosome 3q29 deletion syndrome; microdeletion 3q29 syndrome; 3qter deletion syn- drome {VN2}: PAK274 DLG171 NCBP253 HES139 RPL35A22 TFRC21 RNF16818 BDH117 PCYT1A15 MUC2013 (14 more . . .) FBXO451 (Implicated Genes from Microarray Studies) (Multiple incl. BCL11A) \u2020\u2021 (Multiple incl. SLC3A1, PREPL) (MBD5) \u2021 (FOXP1) \u2020\u2021 (DRD3, ZBTB20 \u2021, GAP43, LSAMP) \u2020\u2021 (Multiple incl. PAK2, DLG1) \u2020\u2021 21 of 33 Reported Effects on Speech Dysarthria, apraxia, or im- paired speech [13] Apraxia or idiosyncratic speech [14] Delayed or impaired speech Absent speech Impaired speech [15] Delayed, idiosyncratic, and impaired speech and dysarthria (all severe), apraxia [16] Impaired [17] or absent speech Delayed speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 4 deletions 4p16.3 OMIM: 194190; Cytogenetic location: 4p16.3 Genomic coordinates (GRCh38): 4:0\u20134,500,000 Names: Wolf\u2013Hirschhorn syndrome; Pitt\u2013Rogers\u2013Danks syndrome; Pitt syndrome; Wittwer syn- drome; Dillan 4p syndrome {VN1} CTBP125 {VN2}: FGFR3109 TNIP232 NELFA27 MIR94326 CTBP125 ADRA2C22 NSD219 GRK415 DGKQ14 PDE6B13 HAUS313 SLC26A112 SLBP12 ATP5ME12 RNF411 CPLX111 RGS1210 (27 more . . .) ZFYVE281 PCGF31 NSG11 MXD41 ABCA11P1 4q21 OMIM: 613509; Cytogenetic location: 4q21 Genomic coordinates (GRCh38): 4:86,000,000\u2013 87,100,000 Names: Chromosome 4q21 deletion syndrome {VN2}: MAPK10122 FGF5118 NUP5479 PAQR347 PRKG227 CXCL1022 CXCL918 ABRAXAS118 SEC31A16 CXCL1116 (31 more . . .) SHROOM31 SEPTIN111 HNRNPDL1 G3BP21 BMP2K1 AFF11 Chromosome 5 deletions 5p (5p15.2 and/or (5p15.3 or 5p15.33)) OMIM: 123450 Names: Chromosome 5p deletion syndrome; cri-du-chat syndrome; cat cry syndrome; Lejeune syndrome; 5p monosomy; partial monosomy 5 {VN2}: ADCY2116 SLC6A373 SDHA37 TERT24 TRIO23 MTRR19 LPCAT115 CEP7215 SRD5A114 SLC9A313 (27 more . . .) OTULINL1 CTNND21 CLPTM1L1 (MEF2C) \u2021 5q14.3 OMIM: 612881 (distal version 5q14.3\u2013q15); Cytogenetic location: 5q14.3\u2013q15 Genomic coordinates (GRCh38): 5:83,500,000\u201398,900,000 Names: Distal chromosome 5q14.3 deletion syndrome; periventricular heterotopia associated with chromosome 5q deletion; periventricular nodular heterotopia 5; PVNH5 {VN2}: RASA189 CCNH74 MEF2C70 POLR3G17 COX7C15 MIR9-27 EDIL33 5q33.1 OMIM: 153550 Names: Chromosome 5q deletion syndrome; 5q syndrome; refractory macrocytic anemia due to 5q deletion; MAR {VN2}: RPS1429 GPX318 DCTN413 SPARC12 SLC36A112 NMUR211 CD7410 NDST19 GM2A8 TNIP16 (7 more . . .) SYNPO1 IRGM1 5q35.3 OMIM: 117550 Names: Sotos syndrome 1; Sotos1; Nevo syndrome; cerebral gigantism, Nevo type; chromosome 5q35 deletion syndrome {VN1} NSD18 {VN2}: MAPK9167 LTC4S53 F1233 SQSTM130 MAML129 RACK125 FLT423 CANX22 GRK620 GRM616 (37 more ."}, {"question": " What does each chain in the table link from the gene shown to?,answer: Each chain forms a link from the gene shown to the ACC biological pathway of FOXP2.", "ref_chunk": "in the voicechains found for the syndrome are shown in bold font. Second column: The second column in this table lists the corresponding speech characteristics, with references. Where no reference is cited, the information is found in the OMIM record for the syndrome (where possible, OMIM references are used for brevity). Table A1. Chainlink genes for level-1 and level-2 voice chain ensembles for 76 chromosomal mi- crodeletion syndromes. Each chain forms a link from the gene shown to the ACC biological pathway of FOXP2 and has been automatically derived. The total number of pathways that each gene in\ufb02u- ences independently is shown as a subscript to its name. Observed phenotypic effects on speech are given in the last column. When references are not cited, the information re\ufb02ects that in the OMIM records for the syndrome. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 1 deletions 1p36 OMIM: 607872; Cytogenetic location: 1p36; Genomic coordinates (GRCh38): 1:23,600,000\u2013 27,600,000 Names: Chromosome 1p36 deletion sydrome; monosomy 1p36 syndrome {VN1} ARID1A10 {VN2}: PIK3CD168 MTOR146 GNB1140 CDC42140 CASP9108 RPS6KA193 PRKCZ75 CNKSR157 SFN55 DVL148 (216 more . . .) SSU721 RBP71 PLEKHN11 PLEKHM21 PEX101 NBL11 MTCO3P121 MMP23B1 MMP23A1 HSPB71 HMGN21 GPR31 EXOSC101 DISP31 CROCCP21 CAMTA11 AHDC11 ACAP31 1q21.1\u2013q21.2 OMIM: 612474/274000, Cytogenetic location: 1q21.1 Genomic coordinates (GRCh38): 1:143,200,000\u2013147,500,000 Names: Thrombocytopenia with absent radius (TAR) syndrome (OMIM 274000) {VN2}: H4C1467 H4C1566 H2BC2163 PRKAB257 H3C1556 H3C1456 H3C1356 H2AC2053 H2AC1953 H2AC1853 (31 more . . .) 1q41\u2013q42 OMIM: 612530; Cytogenetic location: 1q41\u2013q42 Genomic coordinates (GRCh38): 1:214,400,000\u2013 236,400,000 Names: Chromosome 1q41\u2013q42 deletion syndrome; holoprosencephaly 10; HPE10 {VN2}: NUP13388 H2BU163 TGFB262 DUSP1054 H3-3A50 WNT3A47 ARF146 PARP141 MIR362038 PSEN236 (50 more . . .) DISP12 MIR2151 MIR194-11 DNAH141 CDC42BPA1 1q43\u2013q44 OMIM: 612337 Names: Mental retardation, autosomal dominant 22; MRD22; chromosome 1q43\u2013q44 deletion syndrome (included); chromosome 1qter deletion syndrome (included) {VN2}: AKT3169 RYR274 ACTN269 CHRM342 MTR38 FH31 ADSS230 EXO126 RGS716 KMO15 (68 more . . .) FMN21 (Implicated Genes from Microarray Studies) (Multiple incl. RERE, SPEN) \u2020\u2021 (Multiple incl. RBM8A \u2020\u2021, GJAS \u2020) (Multiple incl. DISP1, HPE10, LEFTY1, LEFTY2, WDR26, TSEN2, BPNT1) \u2020\u2021 (AKT3, ZBTB18) \u2021 Reported Effects on Speech Delayed [9] or absent speech Delayed [10] or Impaired [11] speech Apraxia [12] Delayed, impaired, or absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 2 deletions 2p16.1\u2013p15 OMIM: 612513; Cytogenetic location: 2p16.1\u2013p15 Genomic coordinates (GRCh38): 2:54,700,000\u2013 63,900,000 Names: Chromosome 2p16.1\u2013p15 deletion syndrome {VN2}: RPS27A293 XPO156 UGP233 MDH127 REL23 CCT414 RTN413 B3GNT212 VRK210 USP347 (7 more . . .) OTX11 CCDC88A1 2p21 OMIM: 606407; Cytogenetic location: 2p21 Genomic coordinates (GRCh38): 2:41,500,000\u2013 47,500,000 Names: Hypotonia\u2013cystinuria syndrome; cystinuria with mitochondrial disease; homozygous 2p21 deletion syndrome {VN2}: CALM2234 PRKCE73 SLC3A136 HAAO22 ATP6V1E219 ABCG518 MSH217 ABCG817 EPAS116 COX7A2L15 (14 more . . .) SIX31 EML41 2q23.1 OMIM: 156200 Names: Mental retardation, autosomal dominant 1; MRD1; chromosome 2q23.1 deletion syndrome {VN2}: ORC429 KIF5C2 2q32\u2013q33 (SATB2) \u2021(HOXD cluster and regulatory elements, COL3A1 COL5A2, GTF3C3, CASP8, CASP10) \u2021\u2021 OMIM: 612313 Names: Glass syndrome; GLASS; chromosome 2q32\u2013q33 deletion syndrome; SATB2-associated syndrome {VN2}: CREB1203 STAT1130 CASP8103 NUP3579 ITGAV64 CD2860 SUMO152 AOX150 FZD543 FZD737 (52 more . . .) TMEFF21 KLF71 HSPE11 DUSP191 DNAH71 (HDAC4) \u2021 2q37.3 OMIM: 600430 (2q37); Cytogenetic location: 2q37 Genomic coordinates (GRCh38): 2:236,400,000\u2013 242,193,529 Names: Chromosome 2q37 deletion syndrome, brachydactyly\u2013intellectual disability syndrome; Albright hereditary osteodystrophy-like syndrome Type 3 {VN2}: HDAC433 GPC127 AGXT25 COL6A319 ACKR314 NEU413 NDUFA1012 PRLH11 PER211 DTYMK11 (28 more . . .) TWIST21 ILKAP1 Chromosome 3 deletions 3p13 OMIM: 613670 Names: Mental retardation with language impairment with or without autistic features {VN2}: MITF19 PROK28 PPP4R25 GPR275 EIF4E35 FOXP13 GXYLT22 RYBP1 3q13.31 OMIM: 615433; Cytogenetic location: 3q13.31 Genomic coordinates (GRCh38): 3:113,700,000\u2013 117,600,000 Names: Chromosome 3q13.31 deletion syndrome {VN2}: DRD322 ATP6V1A22 GAP436 QTRT23 LSAMP3 3q29 OMIM: 609425; Cytogenetic location: 3q29 Genomic coordinates (GRCh38): 3:192,600,000\u2013 198,295,559 Names: Chromosome 3q29 deletion syndrome; microdeletion 3q29 syndrome; 3qter deletion syn- drome {VN2}: PAK274 DLG171 NCBP253 HES139 RPL35A22 TFRC21 RNF16818 BDH117 PCYT1A15 MUC2013 (14 more . . .) FBXO451 (Implicated Genes from Microarray Studies) (Multiple incl. BCL11A) \u2020\u2021 (Multiple incl. SLC3A1, PREPL) (MBD5) \u2021 (FOXP1) \u2020\u2021 (DRD3, ZBTB20 \u2021, GAP43, LSAMP) \u2020\u2021 (Multiple incl. PAK2, DLG1) \u2020\u2021 21 of 33 Reported Effects on Speech Dysarthria, apraxia, or im- paired speech [13] Apraxia or idiosyncratic speech [14] Delayed or impaired speech Absent speech Impaired speech [15] Delayed, idiosyncratic, and impaired speech and dysarthria (all severe), apraxia [16] Impaired [17] or absent speech Delayed speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 4 deletions 4p16.3 OMIM: 194190; Cytogenetic location: 4p16.3 Genomic coordinates (GRCh38): 4:0\u20134,500,000 Names: Wolf\u2013Hirschhorn syndrome; Pitt\u2013Rogers\u2013Danks syndrome; Pitt syndrome; Wittwer syn- drome; Dillan 4p syndrome {VN1} CTBP125 {VN2}: FGFR3109 TNIP232 NELFA27 MIR94326 CTBP125 ADRA2C22 NSD219 GRK415 DGKQ14 PDE6B13 HAUS313 SLC26A112 SLBP12 ATP5ME12 RNF411 CPLX111 RGS1210 (27 more . . .) ZFYVE281 PCGF31 NSG11 MXD41 ABCA11P1 4q21 OMIM: 613509; Cytogenetic location: 4q21 Genomic coordinates (GRCh38): 4:86,000,000\u2013 87,100,000 Names: Chromosome 4q21 deletion syndrome {VN2}: MAPK10122 FGF5118 NUP5479 PAQR347 PRKG227 CXCL1022 CXCL918 ABRAXAS118 SEC31A16 CXCL1116 (31 more . . .) SHROOM31 SEPTIN111 HNRNPDL1 G3BP21 BMP2K1 AFF11 Chromosome 5 deletions 5p (5p15.2 and/or (5p15.3 or 5p15.33)) OMIM: 123450 Names: Chromosome 5p deletion syndrome; cri-du-chat syndrome; cat cry syndrome; Lejeune syndrome; 5p monosomy; partial monosomy 5 {VN2}: ADCY2116 SLC6A373 SDHA37 TERT24 TRIO23 MTRR19 LPCAT115 CEP7215 SRD5A114 SLC9A313 (27 more . . .) OTULINL1 CTNND21 CLPTM1L1 (MEF2C) \u2021 5q14.3 OMIM: 612881 (distal version 5q14.3\u2013q15); Cytogenetic location: 5q14.3\u2013q15 Genomic coordinates (GRCh38): 5:83,500,000\u201398,900,000 Names: Distal chromosome 5q14.3 deletion syndrome; periventricular heterotopia associated with chromosome 5q deletion; periventricular nodular heterotopia 5; PVNH5 {VN2}: RASA189 CCNH74 MEF2C70 POLR3G17 COX7C15 MIR9-27 EDIL33 5q33.1 OMIM: 153550 Names: Chromosome 5q deletion syndrome; 5q syndrome; refractory macrocytic anemia due to 5q deletion; MAR {VN2}: RPS1429 GPX318 DCTN413 SPARC12 SLC36A112 NMUR211 CD7410 NDST19 GM2A8 TNIP16 (7 more . . .) SYNPO1 IRGM1 5q35.3 OMIM: 117550 Names: Sotos syndrome 1; Sotos1; Nevo syndrome; cerebral gigantism, Nevo type; chromosome 5q35 deletion syndrome {VN1} NSD18 {VN2}: MAPK9167 LTC4S53 F1233 SQSTM130 MAML129 RACK125 FLT423 CANX22 GRK620 GRM616 (37 more ."}, {"question": " What is the total number of pathways that each gene influences independently shown as in the table?,answer: The total number of pathways each gene influences independently is shown as a subscript to its name.", "ref_chunk": "in the voicechains found for the syndrome are shown in bold font. Second column: The second column in this table lists the corresponding speech characteristics, with references. Where no reference is cited, the information is found in the OMIM record for the syndrome (where possible, OMIM references are used for brevity). Table A1. Chainlink genes for level-1 and level-2 voice chain ensembles for 76 chromosomal mi- crodeletion syndromes. Each chain forms a link from the gene shown to the ACC biological pathway of FOXP2 and has been automatically derived. The total number of pathways that each gene in\ufb02u- ences independently is shown as a subscript to its name. Observed phenotypic effects on speech are given in the last column. When references are not cited, the information re\ufb02ects that in the OMIM records for the syndrome. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 1 deletions 1p36 OMIM: 607872; Cytogenetic location: 1p36; Genomic coordinates (GRCh38): 1:23,600,000\u2013 27,600,000 Names: Chromosome 1p36 deletion sydrome; monosomy 1p36 syndrome {VN1} ARID1A10 {VN2}: PIK3CD168 MTOR146 GNB1140 CDC42140 CASP9108 RPS6KA193 PRKCZ75 CNKSR157 SFN55 DVL148 (216 more . . .) SSU721 RBP71 PLEKHN11 PLEKHM21 PEX101 NBL11 MTCO3P121 MMP23B1 MMP23A1 HSPB71 HMGN21 GPR31 EXOSC101 DISP31 CROCCP21 CAMTA11 AHDC11 ACAP31 1q21.1\u2013q21.2 OMIM: 612474/274000, Cytogenetic location: 1q21.1 Genomic coordinates (GRCh38): 1:143,200,000\u2013147,500,000 Names: Thrombocytopenia with absent radius (TAR) syndrome (OMIM 274000) {VN2}: H4C1467 H4C1566 H2BC2163 PRKAB257 H3C1556 H3C1456 H3C1356 H2AC2053 H2AC1953 H2AC1853 (31 more . . .) 1q41\u2013q42 OMIM: 612530; Cytogenetic location: 1q41\u2013q42 Genomic coordinates (GRCh38): 1:214,400,000\u2013 236,400,000 Names: Chromosome 1q41\u2013q42 deletion syndrome; holoprosencephaly 10; HPE10 {VN2}: NUP13388 H2BU163 TGFB262 DUSP1054 H3-3A50 WNT3A47 ARF146 PARP141 MIR362038 PSEN236 (50 more . . .) DISP12 MIR2151 MIR194-11 DNAH141 CDC42BPA1 1q43\u2013q44 OMIM: 612337 Names: Mental retardation, autosomal dominant 22; MRD22; chromosome 1q43\u2013q44 deletion syndrome (included); chromosome 1qter deletion syndrome (included) {VN2}: AKT3169 RYR274 ACTN269 CHRM342 MTR38 FH31 ADSS230 EXO126 RGS716 KMO15 (68 more . . .) FMN21 (Implicated Genes from Microarray Studies) (Multiple incl. RERE, SPEN) \u2020\u2021 (Multiple incl. RBM8A \u2020\u2021, GJAS \u2020) (Multiple incl. DISP1, HPE10, LEFTY1, LEFTY2, WDR26, TSEN2, BPNT1) \u2020\u2021 (AKT3, ZBTB18) \u2021 Reported Effects on Speech Delayed [9] or absent speech Delayed [10] or Impaired [11] speech Apraxia [12] Delayed, impaired, or absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 2 deletions 2p16.1\u2013p15 OMIM: 612513; Cytogenetic location: 2p16.1\u2013p15 Genomic coordinates (GRCh38): 2:54,700,000\u2013 63,900,000 Names: Chromosome 2p16.1\u2013p15 deletion syndrome {VN2}: RPS27A293 XPO156 UGP233 MDH127 REL23 CCT414 RTN413 B3GNT212 VRK210 USP347 (7 more . . .) OTX11 CCDC88A1 2p21 OMIM: 606407; Cytogenetic location: 2p21 Genomic coordinates (GRCh38): 2:41,500,000\u2013 47,500,000 Names: Hypotonia\u2013cystinuria syndrome; cystinuria with mitochondrial disease; homozygous 2p21 deletion syndrome {VN2}: CALM2234 PRKCE73 SLC3A136 HAAO22 ATP6V1E219 ABCG518 MSH217 ABCG817 EPAS116 COX7A2L15 (14 more . . .) SIX31 EML41 2q23.1 OMIM: 156200 Names: Mental retardation, autosomal dominant 1; MRD1; chromosome 2q23.1 deletion syndrome {VN2}: ORC429 KIF5C2 2q32\u2013q33 (SATB2) \u2021(HOXD cluster and regulatory elements, COL3A1 COL5A2, GTF3C3, CASP8, CASP10) \u2021\u2021 OMIM: 612313 Names: Glass syndrome; GLASS; chromosome 2q32\u2013q33 deletion syndrome; SATB2-associated syndrome {VN2}: CREB1203 STAT1130 CASP8103 NUP3579 ITGAV64 CD2860 SUMO152 AOX150 FZD543 FZD737 (52 more . . .) TMEFF21 KLF71 HSPE11 DUSP191 DNAH71 (HDAC4) \u2021 2q37.3 OMIM: 600430 (2q37); Cytogenetic location: 2q37 Genomic coordinates (GRCh38): 2:236,400,000\u2013 242,193,529 Names: Chromosome 2q37 deletion syndrome, brachydactyly\u2013intellectual disability syndrome; Albright hereditary osteodystrophy-like syndrome Type 3 {VN2}: HDAC433 GPC127 AGXT25 COL6A319 ACKR314 NEU413 NDUFA1012 PRLH11 PER211 DTYMK11 (28 more . . .) TWIST21 ILKAP1 Chromosome 3 deletions 3p13 OMIM: 613670 Names: Mental retardation with language impairment with or without autistic features {VN2}: MITF19 PROK28 PPP4R25 GPR275 EIF4E35 FOXP13 GXYLT22 RYBP1 3q13.31 OMIM: 615433; Cytogenetic location: 3q13.31 Genomic coordinates (GRCh38): 3:113,700,000\u2013 117,600,000 Names: Chromosome 3q13.31 deletion syndrome {VN2}: DRD322 ATP6V1A22 GAP436 QTRT23 LSAMP3 3q29 OMIM: 609425; Cytogenetic location: 3q29 Genomic coordinates (GRCh38): 3:192,600,000\u2013 198,295,559 Names: Chromosome 3q29 deletion syndrome; microdeletion 3q29 syndrome; 3qter deletion syn- drome {VN2}: PAK274 DLG171 NCBP253 HES139 RPL35A22 TFRC21 RNF16818 BDH117 PCYT1A15 MUC2013 (14 more . . .) FBXO451 (Implicated Genes from Microarray Studies) (Multiple incl. BCL11A) \u2020\u2021 (Multiple incl. SLC3A1, PREPL) (MBD5) \u2021 (FOXP1) \u2020\u2021 (DRD3, ZBTB20 \u2021, GAP43, LSAMP) \u2020\u2021 (Multiple incl. PAK2, DLG1) \u2020\u2021 21 of 33 Reported Effects on Speech Dysarthria, apraxia, or im- paired speech [13] Apraxia or idiosyncratic speech [14] Delayed or impaired speech Absent speech Impaired speech [15] Delayed, idiosyncratic, and impaired speech and dysarthria (all severe), apraxia [16] Impaired [17] or absent speech Delayed speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 4 deletions 4p16.3 OMIM: 194190; Cytogenetic location: 4p16.3 Genomic coordinates (GRCh38): 4:0\u20134,500,000 Names: Wolf\u2013Hirschhorn syndrome; Pitt\u2013Rogers\u2013Danks syndrome; Pitt syndrome; Wittwer syn- drome; Dillan 4p syndrome {VN1} CTBP125 {VN2}: FGFR3109 TNIP232 NELFA27 MIR94326 CTBP125 ADRA2C22 NSD219 GRK415 DGKQ14 PDE6B13 HAUS313 SLC26A112 SLBP12 ATP5ME12 RNF411 CPLX111 RGS1210 (27 more . . .) ZFYVE281 PCGF31 NSG11 MXD41 ABCA11P1 4q21 OMIM: 613509; Cytogenetic location: 4q21 Genomic coordinates (GRCh38): 4:86,000,000\u2013 87,100,000 Names: Chromosome 4q21 deletion syndrome {VN2}: MAPK10122 FGF5118 NUP5479 PAQR347 PRKG227 CXCL1022 CXCL918 ABRAXAS118 SEC31A16 CXCL1116 (31 more . . .) SHROOM31 SEPTIN111 HNRNPDL1 G3BP21 BMP2K1 AFF11 Chromosome 5 deletions 5p (5p15.2 and/or (5p15.3 or 5p15.33)) OMIM: 123450 Names: Chromosome 5p deletion syndrome; cri-du-chat syndrome; cat cry syndrome; Lejeune syndrome; 5p monosomy; partial monosomy 5 {VN2}: ADCY2116 SLC6A373 SDHA37 TERT24 TRIO23 MTRR19 LPCAT115 CEP7215 SRD5A114 SLC9A313 (27 more . . .) OTULINL1 CTNND21 CLPTM1L1 (MEF2C) \u2021 5q14.3 OMIM: 612881 (distal version 5q14.3\u2013q15); Cytogenetic location: 5q14.3\u2013q15 Genomic coordinates (GRCh38): 5:83,500,000\u201398,900,000 Names: Distal chromosome 5q14.3 deletion syndrome; periventricular heterotopia associated with chromosome 5q deletion; periventricular nodular heterotopia 5; PVNH5 {VN2}: RASA189 CCNH74 MEF2C70 POLR3G17 COX7C15 MIR9-27 EDIL33 5q33.1 OMIM: 153550 Names: Chromosome 5q deletion syndrome; 5q syndrome; refractory macrocytic anemia due to 5q deletion; MAR {VN2}: RPS1429 GPX318 DCTN413 SPARC12 SLC36A112 NMUR211 CD7410 NDST19 GM2A8 TNIP16 (7 more . . .) SYNPO1 IRGM1 5q35.3 OMIM: 117550 Names: Sotos syndrome 1; Sotos1; Nevo syndrome; cerebral gigantism, Nevo type; chromosome 5q35 deletion syndrome {VN1} NSD18 {VN2}: MAPK9167 LTC4S53 F1233 SQSTM130 MAML129 RACK125 FLT423 CANX22 GRK620 GRM616 (37 more ."}, {"question": " What are some observed phenotypic effects on speech given in the last column of the table?,answer: Observed phenotypic effects on speech given in the last column include delayed, impaired, or absent speech.", "ref_chunk": "in the voicechains found for the syndrome are shown in bold font. Second column: The second column in this table lists the corresponding speech characteristics, with references. Where no reference is cited, the information is found in the OMIM record for the syndrome (where possible, OMIM references are used for brevity). Table A1. Chainlink genes for level-1 and level-2 voice chain ensembles for 76 chromosomal mi- crodeletion syndromes. Each chain forms a link from the gene shown to the ACC biological pathway of FOXP2 and has been automatically derived. The total number of pathways that each gene in\ufb02u- ences independently is shown as a subscript to its name. Observed phenotypic effects on speech are given in the last column. When references are not cited, the information re\ufb02ects that in the OMIM records for the syndrome. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 1 deletions 1p36 OMIM: 607872; Cytogenetic location: 1p36; Genomic coordinates (GRCh38): 1:23,600,000\u2013 27,600,000 Names: Chromosome 1p36 deletion sydrome; monosomy 1p36 syndrome {VN1} ARID1A10 {VN2}: PIK3CD168 MTOR146 GNB1140 CDC42140 CASP9108 RPS6KA193 PRKCZ75 CNKSR157 SFN55 DVL148 (216 more . . .) SSU721 RBP71 PLEKHN11 PLEKHM21 PEX101 NBL11 MTCO3P121 MMP23B1 MMP23A1 HSPB71 HMGN21 GPR31 EXOSC101 DISP31 CROCCP21 CAMTA11 AHDC11 ACAP31 1q21.1\u2013q21.2 OMIM: 612474/274000, Cytogenetic location: 1q21.1 Genomic coordinates (GRCh38): 1:143,200,000\u2013147,500,000 Names: Thrombocytopenia with absent radius (TAR) syndrome (OMIM 274000) {VN2}: H4C1467 H4C1566 H2BC2163 PRKAB257 H3C1556 H3C1456 H3C1356 H2AC2053 H2AC1953 H2AC1853 (31 more . . .) 1q41\u2013q42 OMIM: 612530; Cytogenetic location: 1q41\u2013q42 Genomic coordinates (GRCh38): 1:214,400,000\u2013 236,400,000 Names: Chromosome 1q41\u2013q42 deletion syndrome; holoprosencephaly 10; HPE10 {VN2}: NUP13388 H2BU163 TGFB262 DUSP1054 H3-3A50 WNT3A47 ARF146 PARP141 MIR362038 PSEN236 (50 more . . .) DISP12 MIR2151 MIR194-11 DNAH141 CDC42BPA1 1q43\u2013q44 OMIM: 612337 Names: Mental retardation, autosomal dominant 22; MRD22; chromosome 1q43\u2013q44 deletion syndrome (included); chromosome 1qter deletion syndrome (included) {VN2}: AKT3169 RYR274 ACTN269 CHRM342 MTR38 FH31 ADSS230 EXO126 RGS716 KMO15 (68 more . . .) FMN21 (Implicated Genes from Microarray Studies) (Multiple incl. RERE, SPEN) \u2020\u2021 (Multiple incl. RBM8A \u2020\u2021, GJAS \u2020) (Multiple incl. DISP1, HPE10, LEFTY1, LEFTY2, WDR26, TSEN2, BPNT1) \u2020\u2021 (AKT3, ZBTB18) \u2021 Reported Effects on Speech Delayed [9] or absent speech Delayed [10] or Impaired [11] speech Apraxia [12] Delayed, impaired, or absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 2 deletions 2p16.1\u2013p15 OMIM: 612513; Cytogenetic location: 2p16.1\u2013p15 Genomic coordinates (GRCh38): 2:54,700,000\u2013 63,900,000 Names: Chromosome 2p16.1\u2013p15 deletion syndrome {VN2}: RPS27A293 XPO156 UGP233 MDH127 REL23 CCT414 RTN413 B3GNT212 VRK210 USP347 (7 more . . .) OTX11 CCDC88A1 2p21 OMIM: 606407; Cytogenetic location: 2p21 Genomic coordinates (GRCh38): 2:41,500,000\u2013 47,500,000 Names: Hypotonia\u2013cystinuria syndrome; cystinuria with mitochondrial disease; homozygous 2p21 deletion syndrome {VN2}: CALM2234 PRKCE73 SLC3A136 HAAO22 ATP6V1E219 ABCG518 MSH217 ABCG817 EPAS116 COX7A2L15 (14 more . . .) SIX31 EML41 2q23.1 OMIM: 156200 Names: Mental retardation, autosomal dominant 1; MRD1; chromosome 2q23.1 deletion syndrome {VN2}: ORC429 KIF5C2 2q32\u2013q33 (SATB2) \u2021(HOXD cluster and regulatory elements, COL3A1 COL5A2, GTF3C3, CASP8, CASP10) \u2021\u2021 OMIM: 612313 Names: Glass syndrome; GLASS; chromosome 2q32\u2013q33 deletion syndrome; SATB2-associated syndrome {VN2}: CREB1203 STAT1130 CASP8103 NUP3579 ITGAV64 CD2860 SUMO152 AOX150 FZD543 FZD737 (52 more . . .) TMEFF21 KLF71 HSPE11 DUSP191 DNAH71 (HDAC4) \u2021 2q37.3 OMIM: 600430 (2q37); Cytogenetic location: 2q37 Genomic coordinates (GRCh38): 2:236,400,000\u2013 242,193,529 Names: Chromosome 2q37 deletion syndrome, brachydactyly\u2013intellectual disability syndrome; Albright hereditary osteodystrophy-like syndrome Type 3 {VN2}: HDAC433 GPC127 AGXT25 COL6A319 ACKR314 NEU413 NDUFA1012 PRLH11 PER211 DTYMK11 (28 more . . .) TWIST21 ILKAP1 Chromosome 3 deletions 3p13 OMIM: 613670 Names: Mental retardation with language impairment with or without autistic features {VN2}: MITF19 PROK28 PPP4R25 GPR275 EIF4E35 FOXP13 GXYLT22 RYBP1 3q13.31 OMIM: 615433; Cytogenetic location: 3q13.31 Genomic coordinates (GRCh38): 3:113,700,000\u2013 117,600,000 Names: Chromosome 3q13.31 deletion syndrome {VN2}: DRD322 ATP6V1A22 GAP436 QTRT23 LSAMP3 3q29 OMIM: 609425; Cytogenetic location: 3q29 Genomic coordinates (GRCh38): 3:192,600,000\u2013 198,295,559 Names: Chromosome 3q29 deletion syndrome; microdeletion 3q29 syndrome; 3qter deletion syn- drome {VN2}: PAK274 DLG171 NCBP253 HES139 RPL35A22 TFRC21 RNF16818 BDH117 PCYT1A15 MUC2013 (14 more . . .) FBXO451 (Implicated Genes from Microarray Studies) (Multiple incl. BCL11A) \u2020\u2021 (Multiple incl. SLC3A1, PREPL) (MBD5) \u2021 (FOXP1) \u2020\u2021 (DRD3, ZBTB20 \u2021, GAP43, LSAMP) \u2020\u2021 (Multiple incl. PAK2, DLG1) \u2020\u2021 21 of 33 Reported Effects on Speech Dysarthria, apraxia, or im- paired speech [13] Apraxia or idiosyncratic speech [14] Delayed or impaired speech Absent speech Impaired speech [15] Delayed, idiosyncratic, and impaired speech and dysarthria (all severe), apraxia [16] Impaired [17] or absent speech Delayed speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 4 deletions 4p16.3 OMIM: 194190; Cytogenetic location: 4p16.3 Genomic coordinates (GRCh38): 4:0\u20134,500,000 Names: Wolf\u2013Hirschhorn syndrome; Pitt\u2013Rogers\u2013Danks syndrome; Pitt syndrome; Wittwer syn- drome; Dillan 4p syndrome {VN1} CTBP125 {VN2}: FGFR3109 TNIP232 NELFA27 MIR94326 CTBP125 ADRA2C22 NSD219 GRK415 DGKQ14 PDE6B13 HAUS313 SLC26A112 SLBP12 ATP5ME12 RNF411 CPLX111 RGS1210 (27 more . . .) ZFYVE281 PCGF31 NSG11 MXD41 ABCA11P1 4q21 OMIM: 613509; Cytogenetic location: 4q21 Genomic coordinates (GRCh38): 4:86,000,000\u2013 87,100,000 Names: Chromosome 4q21 deletion syndrome {VN2}: MAPK10122 FGF5118 NUP5479 PAQR347 PRKG227 CXCL1022 CXCL918 ABRAXAS118 SEC31A16 CXCL1116 (31 more . . .) SHROOM31 SEPTIN111 HNRNPDL1 G3BP21 BMP2K1 AFF11 Chromosome 5 deletions 5p (5p15.2 and/or (5p15.3 or 5p15.33)) OMIM: 123450 Names: Chromosome 5p deletion syndrome; cri-du-chat syndrome; cat cry syndrome; Lejeune syndrome; 5p monosomy; partial monosomy 5 {VN2}: ADCY2116 SLC6A373 SDHA37 TERT24 TRIO23 MTRR19 LPCAT115 CEP7215 SRD5A114 SLC9A313 (27 more . . .) OTULINL1 CTNND21 CLPTM1L1 (MEF2C) \u2021 5q14.3 OMIM: 612881 (distal version 5q14.3\u2013q15); Cytogenetic location: 5q14.3\u2013q15 Genomic coordinates (GRCh38): 5:83,500,000\u201398,900,000 Names: Distal chromosome 5q14.3 deletion syndrome; periventricular heterotopia associated with chromosome 5q deletion; periventricular nodular heterotopia 5; PVNH5 {VN2}: RASA189 CCNH74 MEF2C70 POLR3G17 COX7C15 MIR9-27 EDIL33 5q33.1 OMIM: 153550 Names: Chromosome 5q deletion syndrome; 5q syndrome; refractory macrocytic anemia due to 5q deletion; MAR {VN2}: RPS1429 GPX318 DCTN413 SPARC12 SLC36A112 NMUR211 CD7410 NDST19 GM2A8 TNIP16 (7 more . . .) SYNPO1 IRGM1 5q35.3 OMIM: 117550 Names: Sotos syndrome 1; Sotos1; Nevo syndrome; cerebral gigantism, Nevo type; chromosome 5q35 deletion syndrome {VN1} NSD18 {VN2}: MAPK9167 LTC4S53 F1233 SQSTM130 MAML129 RACK125 FLT423 CANX22 GRK620 GRM616 (37 more ."}, {"question": " What is the syndrome associated with Chromosome 1 deletions at 1p36 and some of the member chainlink genes?,answer: The syndrome associated is Chromosome 1p36 deletion syndrome and some member chainlink genes are ARID1A10, PIK3CD168, MTOR146, etc.", "ref_chunk": "in the voicechains found for the syndrome are shown in bold font. Second column: The second column in this table lists the corresponding speech characteristics, with references. Where no reference is cited, the information is found in the OMIM record for the syndrome (where possible, OMIM references are used for brevity). Table A1. Chainlink genes for level-1 and level-2 voice chain ensembles for 76 chromosomal mi- crodeletion syndromes. Each chain forms a link from the gene shown to the ACC biological pathway of FOXP2 and has been automatically derived. The total number of pathways that each gene in\ufb02u- ences independently is shown as a subscript to its name. Observed phenotypic effects on speech are given in the last column. When references are not cited, the information re\ufb02ects that in the OMIM records for the syndrome. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 1 deletions 1p36 OMIM: 607872; Cytogenetic location: 1p36; Genomic coordinates (GRCh38): 1:23,600,000\u2013 27,600,000 Names: Chromosome 1p36 deletion sydrome; monosomy 1p36 syndrome {VN1} ARID1A10 {VN2}: PIK3CD168 MTOR146 GNB1140 CDC42140 CASP9108 RPS6KA193 PRKCZ75 CNKSR157 SFN55 DVL148 (216 more . . .) SSU721 RBP71 PLEKHN11 PLEKHM21 PEX101 NBL11 MTCO3P121 MMP23B1 MMP23A1 HSPB71 HMGN21 GPR31 EXOSC101 DISP31 CROCCP21 CAMTA11 AHDC11 ACAP31 1q21.1\u2013q21.2 OMIM: 612474/274000, Cytogenetic location: 1q21.1 Genomic coordinates (GRCh38): 1:143,200,000\u2013147,500,000 Names: Thrombocytopenia with absent radius (TAR) syndrome (OMIM 274000) {VN2}: H4C1467 H4C1566 H2BC2163 PRKAB257 H3C1556 H3C1456 H3C1356 H2AC2053 H2AC1953 H2AC1853 (31 more . . .) 1q41\u2013q42 OMIM: 612530; Cytogenetic location: 1q41\u2013q42 Genomic coordinates (GRCh38): 1:214,400,000\u2013 236,400,000 Names: Chromosome 1q41\u2013q42 deletion syndrome; holoprosencephaly 10; HPE10 {VN2}: NUP13388 H2BU163 TGFB262 DUSP1054 H3-3A50 WNT3A47 ARF146 PARP141 MIR362038 PSEN236 (50 more . . .) DISP12 MIR2151 MIR194-11 DNAH141 CDC42BPA1 1q43\u2013q44 OMIM: 612337 Names: Mental retardation, autosomal dominant 22; MRD22; chromosome 1q43\u2013q44 deletion syndrome (included); chromosome 1qter deletion syndrome (included) {VN2}: AKT3169 RYR274 ACTN269 CHRM342 MTR38 FH31 ADSS230 EXO126 RGS716 KMO15 (68 more . . .) FMN21 (Implicated Genes from Microarray Studies) (Multiple incl. RERE, SPEN) \u2020\u2021 (Multiple incl. RBM8A \u2020\u2021, GJAS \u2020) (Multiple incl. DISP1, HPE10, LEFTY1, LEFTY2, WDR26, TSEN2, BPNT1) \u2020\u2021 (AKT3, ZBTB18) \u2021 Reported Effects on Speech Delayed [9] or absent speech Delayed [10] or Impaired [11] speech Apraxia [12] Delayed, impaired, or absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 2 deletions 2p16.1\u2013p15 OMIM: 612513; Cytogenetic location: 2p16.1\u2013p15 Genomic coordinates (GRCh38): 2:54,700,000\u2013 63,900,000 Names: Chromosome 2p16.1\u2013p15 deletion syndrome {VN2}: RPS27A293 XPO156 UGP233 MDH127 REL23 CCT414 RTN413 B3GNT212 VRK210 USP347 (7 more . . .) OTX11 CCDC88A1 2p21 OMIM: 606407; Cytogenetic location: 2p21 Genomic coordinates (GRCh38): 2:41,500,000\u2013 47,500,000 Names: Hypotonia\u2013cystinuria syndrome; cystinuria with mitochondrial disease; homozygous 2p21 deletion syndrome {VN2}: CALM2234 PRKCE73 SLC3A136 HAAO22 ATP6V1E219 ABCG518 MSH217 ABCG817 EPAS116 COX7A2L15 (14 more . . .) SIX31 EML41 2q23.1 OMIM: 156200 Names: Mental retardation, autosomal dominant 1; MRD1; chromosome 2q23.1 deletion syndrome {VN2}: ORC429 KIF5C2 2q32\u2013q33 (SATB2) \u2021(HOXD cluster and regulatory elements, COL3A1 COL5A2, GTF3C3, CASP8, CASP10) \u2021\u2021 OMIM: 612313 Names: Glass syndrome; GLASS; chromosome 2q32\u2013q33 deletion syndrome; SATB2-associated syndrome {VN2}: CREB1203 STAT1130 CASP8103 NUP3579 ITGAV64 CD2860 SUMO152 AOX150 FZD543 FZD737 (52 more . . .) TMEFF21 KLF71 HSPE11 DUSP191 DNAH71 (HDAC4) \u2021 2q37.3 OMIM: 600430 (2q37); Cytogenetic location: 2q37 Genomic coordinates (GRCh38): 2:236,400,000\u2013 242,193,529 Names: Chromosome 2q37 deletion syndrome, brachydactyly\u2013intellectual disability syndrome; Albright hereditary osteodystrophy-like syndrome Type 3 {VN2}: HDAC433 GPC127 AGXT25 COL6A319 ACKR314 NEU413 NDUFA1012 PRLH11 PER211 DTYMK11 (28 more . . .) TWIST21 ILKAP1 Chromosome 3 deletions 3p13 OMIM: 613670 Names: Mental retardation with language impairment with or without autistic features {VN2}: MITF19 PROK28 PPP4R25 GPR275 EIF4E35 FOXP13 GXYLT22 RYBP1 3q13.31 OMIM: 615433; Cytogenetic location: 3q13.31 Genomic coordinates (GRCh38): 3:113,700,000\u2013 117,600,000 Names: Chromosome 3q13.31 deletion syndrome {VN2}: DRD322 ATP6V1A22 GAP436 QTRT23 LSAMP3 3q29 OMIM: 609425; Cytogenetic location: 3q29 Genomic coordinates (GRCh38): 3:192,600,000\u2013 198,295,559 Names: Chromosome 3q29 deletion syndrome; microdeletion 3q29 syndrome; 3qter deletion syn- drome {VN2}: PAK274 DLG171 NCBP253 HES139 RPL35A22 TFRC21 RNF16818 BDH117 PCYT1A15 MUC2013 (14 more . . .) FBXO451 (Implicated Genes from Microarray Studies) (Multiple incl. BCL11A) \u2020\u2021 (Multiple incl. SLC3A1, PREPL) (MBD5) \u2021 (FOXP1) \u2020\u2021 (DRD3, ZBTB20 \u2021, GAP43, LSAMP) \u2020\u2021 (Multiple incl. PAK2, DLG1) \u2020\u2021 21 of 33 Reported Effects on Speech Dysarthria, apraxia, or im- paired speech [13] Apraxia or idiosyncratic speech [14] Delayed or impaired speech Absent speech Impaired speech [15] Delayed, idiosyncratic, and impaired speech and dysarthria (all severe), apraxia [16] Impaired [17] or absent speech Delayed speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 4 deletions 4p16.3 OMIM: 194190; Cytogenetic location: 4p16.3 Genomic coordinates (GRCh38): 4:0\u20134,500,000 Names: Wolf\u2013Hirschhorn syndrome; Pitt\u2013Rogers\u2013Danks syndrome; Pitt syndrome; Wittwer syn- drome; Dillan 4p syndrome {VN1} CTBP125 {VN2}: FGFR3109 TNIP232 NELFA27 MIR94326 CTBP125 ADRA2C22 NSD219 GRK415 DGKQ14 PDE6B13 HAUS313 SLC26A112 SLBP12 ATP5ME12 RNF411 CPLX111 RGS1210 (27 more . . .) ZFYVE281 PCGF31 NSG11 MXD41 ABCA11P1 4q21 OMIM: 613509; Cytogenetic location: 4q21 Genomic coordinates (GRCh38): 4:86,000,000\u2013 87,100,000 Names: Chromosome 4q21 deletion syndrome {VN2}: MAPK10122 FGF5118 NUP5479 PAQR347 PRKG227 CXCL1022 CXCL918 ABRAXAS118 SEC31A16 CXCL1116 (31 more . . .) SHROOM31 SEPTIN111 HNRNPDL1 G3BP21 BMP2K1 AFF11 Chromosome 5 deletions 5p (5p15.2 and/or (5p15.3 or 5p15.33)) OMIM: 123450 Names: Chromosome 5p deletion syndrome; cri-du-chat syndrome; cat cry syndrome; Lejeune syndrome; 5p monosomy; partial monosomy 5 {VN2}: ADCY2116 SLC6A373 SDHA37 TERT24 TRIO23 MTRR19 LPCAT115 CEP7215 SRD5A114 SLC9A313 (27 more . . .) OTULINL1 CTNND21 CLPTM1L1 (MEF2C) \u2021 5q14.3 OMIM: 612881 (distal version 5q14.3\u2013q15); Cytogenetic location: 5q14.3\u2013q15 Genomic coordinates (GRCh38): 5:83,500,000\u201398,900,000 Names: Distal chromosome 5q14.3 deletion syndrome; periventricular heterotopia associated with chromosome 5q deletion; periventricular nodular heterotopia 5; PVNH5 {VN2}: RASA189 CCNH74 MEF2C70 POLR3G17 COX7C15 MIR9-27 EDIL33 5q33.1 OMIM: 153550 Names: Chromosome 5q deletion syndrome; 5q syndrome; refractory macrocytic anemia due to 5q deletion; MAR {VN2}: RPS1429 GPX318 DCTN413 SPARC12 SLC36A112 NMUR211 CD7410 NDST19 GM2A8 TNIP16 (7 more . . .) SYNPO1 IRGM1 5q35.3 OMIM: 117550 Names: Sotos syndrome 1; Sotos1; Nevo syndrome; cerebral gigantism, Nevo type; chromosome 5q35 deletion syndrome {VN1} NSD18 {VN2}: MAPK9167 LTC4S53 F1233 SQSTM130 MAML129 RACK125 FLT423 CANX22 GRK620 GRM616 (37 more ."}, {"question": " What is the syndrome associated with Chromosome 2 deletions at 2p16.1\u2013p15 and some member chainlink genes?,answer: The syndrome associated is Chromosome 2p16.1\u2013p15 deletion syndrome and some member chainlink genes are RPS27A293, XPO156, UGP233, etc.", "ref_chunk": "in the voicechains found for the syndrome are shown in bold font. Second column: The second column in this table lists the corresponding speech characteristics, with references. Where no reference is cited, the information is found in the OMIM record for the syndrome (where possible, OMIM references are used for brevity). Table A1. Chainlink genes for level-1 and level-2 voice chain ensembles for 76 chromosomal mi- crodeletion syndromes. Each chain forms a link from the gene shown to the ACC biological pathway of FOXP2 and has been automatically derived. The total number of pathways that each gene in\ufb02u- ences independently is shown as a subscript to its name. Observed phenotypic effects on speech are given in the last column. When references are not cited, the information re\ufb02ects that in the OMIM records for the syndrome. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 1 deletions 1p36 OMIM: 607872; Cytogenetic location: 1p36; Genomic coordinates (GRCh38): 1:23,600,000\u2013 27,600,000 Names: Chromosome 1p36 deletion sydrome; monosomy 1p36 syndrome {VN1} ARID1A10 {VN2}: PIK3CD168 MTOR146 GNB1140 CDC42140 CASP9108 RPS6KA193 PRKCZ75 CNKSR157 SFN55 DVL148 (216 more . . .) SSU721 RBP71 PLEKHN11 PLEKHM21 PEX101 NBL11 MTCO3P121 MMP23B1 MMP23A1 HSPB71 HMGN21 GPR31 EXOSC101 DISP31 CROCCP21 CAMTA11 AHDC11 ACAP31 1q21.1\u2013q21.2 OMIM: 612474/274000, Cytogenetic location: 1q21.1 Genomic coordinates (GRCh38): 1:143,200,000\u2013147,500,000 Names: Thrombocytopenia with absent radius (TAR) syndrome (OMIM 274000) {VN2}: H4C1467 H4C1566 H2BC2163 PRKAB257 H3C1556 H3C1456 H3C1356 H2AC2053 H2AC1953 H2AC1853 (31 more . . .) 1q41\u2013q42 OMIM: 612530; Cytogenetic location: 1q41\u2013q42 Genomic coordinates (GRCh38): 1:214,400,000\u2013 236,400,000 Names: Chromosome 1q41\u2013q42 deletion syndrome; holoprosencephaly 10; HPE10 {VN2}: NUP13388 H2BU163 TGFB262 DUSP1054 H3-3A50 WNT3A47 ARF146 PARP141 MIR362038 PSEN236 (50 more . . .) DISP12 MIR2151 MIR194-11 DNAH141 CDC42BPA1 1q43\u2013q44 OMIM: 612337 Names: Mental retardation, autosomal dominant 22; MRD22; chromosome 1q43\u2013q44 deletion syndrome (included); chromosome 1qter deletion syndrome (included) {VN2}: AKT3169 RYR274 ACTN269 CHRM342 MTR38 FH31 ADSS230 EXO126 RGS716 KMO15 (68 more . . .) FMN21 (Implicated Genes from Microarray Studies) (Multiple incl. RERE, SPEN) \u2020\u2021 (Multiple incl. RBM8A \u2020\u2021, GJAS \u2020) (Multiple incl. DISP1, HPE10, LEFTY1, LEFTY2, WDR26, TSEN2, BPNT1) \u2020\u2021 (AKT3, ZBTB18) \u2021 Reported Effects on Speech Delayed [9] or absent speech Delayed [10] or Impaired [11] speech Apraxia [12] Delayed, impaired, or absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 2 deletions 2p16.1\u2013p15 OMIM: 612513; Cytogenetic location: 2p16.1\u2013p15 Genomic coordinates (GRCh38): 2:54,700,000\u2013 63,900,000 Names: Chromosome 2p16.1\u2013p15 deletion syndrome {VN2}: RPS27A293 XPO156 UGP233 MDH127 REL23 CCT414 RTN413 B3GNT212 VRK210 USP347 (7 more . . .) OTX11 CCDC88A1 2p21 OMIM: 606407; Cytogenetic location: 2p21 Genomic coordinates (GRCh38): 2:41,500,000\u2013 47,500,000 Names: Hypotonia\u2013cystinuria syndrome; cystinuria with mitochondrial disease; homozygous 2p21 deletion syndrome {VN2}: CALM2234 PRKCE73 SLC3A136 HAAO22 ATP6V1E219 ABCG518 MSH217 ABCG817 EPAS116 COX7A2L15 (14 more . . .) SIX31 EML41 2q23.1 OMIM: 156200 Names: Mental retardation, autosomal dominant 1; MRD1; chromosome 2q23.1 deletion syndrome {VN2}: ORC429 KIF5C2 2q32\u2013q33 (SATB2) \u2021(HOXD cluster and regulatory elements, COL3A1 COL5A2, GTF3C3, CASP8, CASP10) \u2021\u2021 OMIM: 612313 Names: Glass syndrome; GLASS; chromosome 2q32\u2013q33 deletion syndrome; SATB2-associated syndrome {VN2}: CREB1203 STAT1130 CASP8103 NUP3579 ITGAV64 CD2860 SUMO152 AOX150 FZD543 FZD737 (52 more . . .) TMEFF21 KLF71 HSPE11 DUSP191 DNAH71 (HDAC4) \u2021 2q37.3 OMIM: 600430 (2q37); Cytogenetic location: 2q37 Genomic coordinates (GRCh38): 2:236,400,000\u2013 242,193,529 Names: Chromosome 2q37 deletion syndrome, brachydactyly\u2013intellectual disability syndrome; Albright hereditary osteodystrophy-like syndrome Type 3 {VN2}: HDAC433 GPC127 AGXT25 COL6A319 ACKR314 NEU413 NDUFA1012 PRLH11 PER211 DTYMK11 (28 more . . .) TWIST21 ILKAP1 Chromosome 3 deletions 3p13 OMIM: 613670 Names: Mental retardation with language impairment with or without autistic features {VN2}: MITF19 PROK28 PPP4R25 GPR275 EIF4E35 FOXP13 GXYLT22 RYBP1 3q13.31 OMIM: 615433; Cytogenetic location: 3q13.31 Genomic coordinates (GRCh38): 3:113,700,000\u2013 117,600,000 Names: Chromosome 3q13.31 deletion syndrome {VN2}: DRD322 ATP6V1A22 GAP436 QTRT23 LSAMP3 3q29 OMIM: 609425; Cytogenetic location: 3q29 Genomic coordinates (GRCh38): 3:192,600,000\u2013 198,295,559 Names: Chromosome 3q29 deletion syndrome; microdeletion 3q29 syndrome; 3qter deletion syn- drome {VN2}: PAK274 DLG171 NCBP253 HES139 RPL35A22 TFRC21 RNF16818 BDH117 PCYT1A15 MUC2013 (14 more . . .) FBXO451 (Implicated Genes from Microarray Studies) (Multiple incl. BCL11A) \u2020\u2021 (Multiple incl. SLC3A1, PREPL) (MBD5) \u2021 (FOXP1) \u2020\u2021 (DRD3, ZBTB20 \u2021, GAP43, LSAMP) \u2020\u2021 (Multiple incl. PAK2, DLG1) \u2020\u2021 21 of 33 Reported Effects on Speech Dysarthria, apraxia, or im- paired speech [13] Apraxia or idiosyncratic speech [14] Delayed or impaired speech Absent speech Impaired speech [15] Delayed, idiosyncratic, and impaired speech and dysarthria (all severe), apraxia [16] Impaired [17] or absent speech Delayed speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 4 deletions 4p16.3 OMIM: 194190; Cytogenetic location: 4p16.3 Genomic coordinates (GRCh38): 4:0\u20134,500,000 Names: Wolf\u2013Hirschhorn syndrome; Pitt\u2013Rogers\u2013Danks syndrome; Pitt syndrome; Wittwer syn- drome; Dillan 4p syndrome {VN1} CTBP125 {VN2}: FGFR3109 TNIP232 NELFA27 MIR94326 CTBP125 ADRA2C22 NSD219 GRK415 DGKQ14 PDE6B13 HAUS313 SLC26A112 SLBP12 ATP5ME12 RNF411 CPLX111 RGS1210 (27 more . . .) ZFYVE281 PCGF31 NSG11 MXD41 ABCA11P1 4q21 OMIM: 613509; Cytogenetic location: 4q21 Genomic coordinates (GRCh38): 4:86,000,000\u2013 87,100,000 Names: Chromosome 4q21 deletion syndrome {VN2}: MAPK10122 FGF5118 NUP5479 PAQR347 PRKG227 CXCL1022 CXCL918 ABRAXAS118 SEC31A16 CXCL1116 (31 more . . .) SHROOM31 SEPTIN111 HNRNPDL1 G3BP21 BMP2K1 AFF11 Chromosome 5 deletions 5p (5p15.2 and/or (5p15.3 or 5p15.33)) OMIM: 123450 Names: Chromosome 5p deletion syndrome; cri-du-chat syndrome; cat cry syndrome; Lejeune syndrome; 5p monosomy; partial monosomy 5 {VN2}: ADCY2116 SLC6A373 SDHA37 TERT24 TRIO23 MTRR19 LPCAT115 CEP7215 SRD5A114 SLC9A313 (27 more . . .) OTULINL1 CTNND21 CLPTM1L1 (MEF2C) \u2021 5q14.3 OMIM: 612881 (distal version 5q14.3\u2013q15); Cytogenetic location: 5q14.3\u2013q15 Genomic coordinates (GRCh38): 5:83,500,000\u201398,900,000 Names: Distal chromosome 5q14.3 deletion syndrome; periventricular heterotopia associated with chromosome 5q deletion; periventricular nodular heterotopia 5; PVNH5 {VN2}: RASA189 CCNH74 MEF2C70 POLR3G17 COX7C15 MIR9-27 EDIL33 5q33.1 OMIM: 153550 Names: Chromosome 5q deletion syndrome; 5q syndrome; refractory macrocytic anemia due to 5q deletion; MAR {VN2}: RPS1429 GPX318 DCTN413 SPARC12 SLC36A112 NMUR211 CD7410 NDST19 GM2A8 TNIP16 (7 more . . .) SYNPO1 IRGM1 5q35.3 OMIM: 117550 Names: Sotos syndrome 1; Sotos1; Nevo syndrome; cerebral gigantism, Nevo type; chromosome 5q35 deletion syndrome {VN1} NSD18 {VN2}: MAPK9167 LTC4S53 F1233 SQSTM130 MAML129 RACK125 FLT423 CANX22 GRK620 GRM616 (37 more ."}, {"question": " What is the syndrome associated with Chromosome 3 deletions at 3p13 and some member chainlink genes?,answer: The associated syndrome is Mental retardation with language impairment with or without autistic features and some member chainlink genes are MITF19, PROK28, PPP4R25, etc.", "ref_chunk": "in the voicechains found for the syndrome are shown in bold font. Second column: The second column in this table lists the corresponding speech characteristics, with references. Where no reference is cited, the information is found in the OMIM record for the syndrome (where possible, OMIM references are used for brevity). Table A1. Chainlink genes for level-1 and level-2 voice chain ensembles for 76 chromosomal mi- crodeletion syndromes. Each chain forms a link from the gene shown to the ACC biological pathway of FOXP2 and has been automatically derived. The total number of pathways that each gene in\ufb02u- ences independently is shown as a subscript to its name. Observed phenotypic effects on speech are given in the last column. When references are not cited, the information re\ufb02ects that in the OMIM records for the syndrome. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 1 deletions 1p36 OMIM: 607872; Cytogenetic location: 1p36; Genomic coordinates (GRCh38): 1:23,600,000\u2013 27,600,000 Names: Chromosome 1p36 deletion sydrome; monosomy 1p36 syndrome {VN1} ARID1A10 {VN2}: PIK3CD168 MTOR146 GNB1140 CDC42140 CASP9108 RPS6KA193 PRKCZ75 CNKSR157 SFN55 DVL148 (216 more . . .) SSU721 RBP71 PLEKHN11 PLEKHM21 PEX101 NBL11 MTCO3P121 MMP23B1 MMP23A1 HSPB71 HMGN21 GPR31 EXOSC101 DISP31 CROCCP21 CAMTA11 AHDC11 ACAP31 1q21.1\u2013q21.2 OMIM: 612474/274000, Cytogenetic location: 1q21.1 Genomic coordinates (GRCh38): 1:143,200,000\u2013147,500,000 Names: Thrombocytopenia with absent radius (TAR) syndrome (OMIM 274000) {VN2}: H4C1467 H4C1566 H2BC2163 PRKAB257 H3C1556 H3C1456 H3C1356 H2AC2053 H2AC1953 H2AC1853 (31 more . . .) 1q41\u2013q42 OMIM: 612530; Cytogenetic location: 1q41\u2013q42 Genomic coordinates (GRCh38): 1:214,400,000\u2013 236,400,000 Names: Chromosome 1q41\u2013q42 deletion syndrome; holoprosencephaly 10; HPE10 {VN2}: NUP13388 H2BU163 TGFB262 DUSP1054 H3-3A50 WNT3A47 ARF146 PARP141 MIR362038 PSEN236 (50 more . . .) DISP12 MIR2151 MIR194-11 DNAH141 CDC42BPA1 1q43\u2013q44 OMIM: 612337 Names: Mental retardation, autosomal dominant 22; MRD22; chromosome 1q43\u2013q44 deletion syndrome (included); chromosome 1qter deletion syndrome (included) {VN2}: AKT3169 RYR274 ACTN269 CHRM342 MTR38 FH31 ADSS230 EXO126 RGS716 KMO15 (68 more . . .) FMN21 (Implicated Genes from Microarray Studies) (Multiple incl. RERE, SPEN) \u2020\u2021 (Multiple incl. RBM8A \u2020\u2021, GJAS \u2020) (Multiple incl. DISP1, HPE10, LEFTY1, LEFTY2, WDR26, TSEN2, BPNT1) \u2020\u2021 (AKT3, ZBTB18) \u2021 Reported Effects on Speech Delayed [9] or absent speech Delayed [10] or Impaired [11] speech Apraxia [12] Delayed, impaired, or absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 2 deletions 2p16.1\u2013p15 OMIM: 612513; Cytogenetic location: 2p16.1\u2013p15 Genomic coordinates (GRCh38): 2:54,700,000\u2013 63,900,000 Names: Chromosome 2p16.1\u2013p15 deletion syndrome {VN2}: RPS27A293 XPO156 UGP233 MDH127 REL23 CCT414 RTN413 B3GNT212 VRK210 USP347 (7 more . . .) OTX11 CCDC88A1 2p21 OMIM: 606407; Cytogenetic location: 2p21 Genomic coordinates (GRCh38): 2:41,500,000\u2013 47,500,000 Names: Hypotonia\u2013cystinuria syndrome; cystinuria with mitochondrial disease; homozygous 2p21 deletion syndrome {VN2}: CALM2234 PRKCE73 SLC3A136 HAAO22 ATP6V1E219 ABCG518 MSH217 ABCG817 EPAS116 COX7A2L15 (14 more . . .) SIX31 EML41 2q23.1 OMIM: 156200 Names: Mental retardation, autosomal dominant 1; MRD1; chromosome 2q23.1 deletion syndrome {VN2}: ORC429 KIF5C2 2q32\u2013q33 (SATB2) \u2021(HOXD cluster and regulatory elements, COL3A1 COL5A2, GTF3C3, CASP8, CASP10) \u2021\u2021 OMIM: 612313 Names: Glass syndrome; GLASS; chromosome 2q32\u2013q33 deletion syndrome; SATB2-associated syndrome {VN2}: CREB1203 STAT1130 CASP8103 NUP3579 ITGAV64 CD2860 SUMO152 AOX150 FZD543 FZD737 (52 more . . .) TMEFF21 KLF71 HSPE11 DUSP191 DNAH71 (HDAC4) \u2021 2q37.3 OMIM: 600430 (2q37); Cytogenetic location: 2q37 Genomic coordinates (GRCh38): 2:236,400,000\u2013 242,193,529 Names: Chromosome 2q37 deletion syndrome, brachydactyly\u2013intellectual disability syndrome; Albright hereditary osteodystrophy-like syndrome Type 3 {VN2}: HDAC433 GPC127 AGXT25 COL6A319 ACKR314 NEU413 NDUFA1012 PRLH11 PER211 DTYMK11 (28 more . . .) TWIST21 ILKAP1 Chromosome 3 deletions 3p13 OMIM: 613670 Names: Mental retardation with language impairment with or without autistic features {VN2}: MITF19 PROK28 PPP4R25 GPR275 EIF4E35 FOXP13 GXYLT22 RYBP1 3q13.31 OMIM: 615433; Cytogenetic location: 3q13.31 Genomic coordinates (GRCh38): 3:113,700,000\u2013 117,600,000 Names: Chromosome 3q13.31 deletion syndrome {VN2}: DRD322 ATP6V1A22 GAP436 QTRT23 LSAMP3 3q29 OMIM: 609425; Cytogenetic location: 3q29 Genomic coordinates (GRCh38): 3:192,600,000\u2013 198,295,559 Names: Chromosome 3q29 deletion syndrome; microdeletion 3q29 syndrome; 3qter deletion syn- drome {VN2}: PAK274 DLG171 NCBP253 HES139 RPL35A22 TFRC21 RNF16818 BDH117 PCYT1A15 MUC2013 (14 more . . .) FBXO451 (Implicated Genes from Microarray Studies) (Multiple incl. BCL11A) \u2020\u2021 (Multiple incl. SLC3A1, PREPL) (MBD5) \u2021 (FOXP1) \u2020\u2021 (DRD3, ZBTB20 \u2021, GAP43, LSAMP) \u2020\u2021 (Multiple incl. PAK2, DLG1) \u2020\u2021 21 of 33 Reported Effects on Speech Dysarthria, apraxia, or im- paired speech [13] Apraxia or idiosyncratic speech [14] Delayed or impaired speech Absent speech Impaired speech [15] Delayed, idiosyncratic, and impaired speech and dysarthria (all severe), apraxia [16] Impaired [17] or absent speech Delayed speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 4 deletions 4p16.3 OMIM: 194190; Cytogenetic location: 4p16.3 Genomic coordinates (GRCh38): 4:0\u20134,500,000 Names: Wolf\u2013Hirschhorn syndrome; Pitt\u2013Rogers\u2013Danks syndrome; Pitt syndrome; Wittwer syn- drome; Dillan 4p syndrome {VN1} CTBP125 {VN2}: FGFR3109 TNIP232 NELFA27 MIR94326 CTBP125 ADRA2C22 NSD219 GRK415 DGKQ14 PDE6B13 HAUS313 SLC26A112 SLBP12 ATP5ME12 RNF411 CPLX111 RGS1210 (27 more . . .) ZFYVE281 PCGF31 NSG11 MXD41 ABCA11P1 4q21 OMIM: 613509; Cytogenetic location: 4q21 Genomic coordinates (GRCh38): 4:86,000,000\u2013 87,100,000 Names: Chromosome 4q21 deletion syndrome {VN2}: MAPK10122 FGF5118 NUP5479 PAQR347 PRKG227 CXCL1022 CXCL918 ABRAXAS118 SEC31A16 CXCL1116 (31 more . . .) SHROOM31 SEPTIN111 HNRNPDL1 G3BP21 BMP2K1 AFF11 Chromosome 5 deletions 5p (5p15.2 and/or (5p15.3 or 5p15.33)) OMIM: 123450 Names: Chromosome 5p deletion syndrome; cri-du-chat syndrome; cat cry syndrome; Lejeune syndrome; 5p monosomy; partial monosomy 5 {VN2}: ADCY2116 SLC6A373 SDHA37 TERT24 TRIO23 MTRR19 LPCAT115 CEP7215 SRD5A114 SLC9A313 (27 more . . .) OTULINL1 CTNND21 CLPTM1L1 (MEF2C) \u2021 5q14.3 OMIM: 612881 (distal version 5q14.3\u2013q15); Cytogenetic location: 5q14.3\u2013q15 Genomic coordinates (GRCh38): 5:83,500,000\u201398,900,000 Names: Distal chromosome 5q14.3 deletion syndrome; periventricular heterotopia associated with chromosome 5q deletion; periventricular nodular heterotopia 5; PVNH5 {VN2}: RASA189 CCNH74 MEF2C70 POLR3G17 COX7C15 MIR9-27 EDIL33 5q33.1 OMIM: 153550 Names: Chromosome 5q deletion syndrome; 5q syndrome; refractory macrocytic anemia due to 5q deletion; MAR {VN2}: RPS1429 GPX318 DCTN413 SPARC12 SLC36A112 NMUR211 CD7410 NDST19 GM2A8 TNIP16 (7 more . . .) SYNPO1 IRGM1 5q35.3 OMIM: 117550 Names: Sotos syndrome 1; Sotos1; Nevo syndrome; cerebral gigantism, Nevo type; chromosome 5q35 deletion syndrome {VN1} NSD18 {VN2}: MAPK9167 LTC4S53 F1233 SQSTM130 MAML129 RACK125 FLT423 CANX22 GRK620 GRM616 (37 more ."}, {"question": " What is the syndrome associated with Chromosome 4 deletions at 4p16.3 and some member chainlink genes?,answer: The syndrome associated is Wolf\u2013Hirschhorn syndrome and some member chainlink genes are CTBP125, FGFR3109, TNIP232, etc.", "ref_chunk": "in the voicechains found for the syndrome are shown in bold font. Second column: The second column in this table lists the corresponding speech characteristics, with references. Where no reference is cited, the information is found in the OMIM record for the syndrome (where possible, OMIM references are used for brevity). Table A1. Chainlink genes for level-1 and level-2 voice chain ensembles for 76 chromosomal mi- crodeletion syndromes. Each chain forms a link from the gene shown to the ACC biological pathway of FOXP2 and has been automatically derived. The total number of pathways that each gene in\ufb02u- ences independently is shown as a subscript to its name. Observed phenotypic effects on speech are given in the last column. When references are not cited, the information re\ufb02ects that in the OMIM records for the syndrome. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 1 deletions 1p36 OMIM: 607872; Cytogenetic location: 1p36; Genomic coordinates (GRCh38): 1:23,600,000\u2013 27,600,000 Names: Chromosome 1p36 deletion sydrome; monosomy 1p36 syndrome {VN1} ARID1A10 {VN2}: PIK3CD168 MTOR146 GNB1140 CDC42140 CASP9108 RPS6KA193 PRKCZ75 CNKSR157 SFN55 DVL148 (216 more . . .) SSU721 RBP71 PLEKHN11 PLEKHM21 PEX101 NBL11 MTCO3P121 MMP23B1 MMP23A1 HSPB71 HMGN21 GPR31 EXOSC101 DISP31 CROCCP21 CAMTA11 AHDC11 ACAP31 1q21.1\u2013q21.2 OMIM: 612474/274000, Cytogenetic location: 1q21.1 Genomic coordinates (GRCh38): 1:143,200,000\u2013147,500,000 Names: Thrombocytopenia with absent radius (TAR) syndrome (OMIM 274000) {VN2}: H4C1467 H4C1566 H2BC2163 PRKAB257 H3C1556 H3C1456 H3C1356 H2AC2053 H2AC1953 H2AC1853 (31 more . . .) 1q41\u2013q42 OMIM: 612530; Cytogenetic location: 1q41\u2013q42 Genomic coordinates (GRCh38): 1:214,400,000\u2013 236,400,000 Names: Chromosome 1q41\u2013q42 deletion syndrome; holoprosencephaly 10; HPE10 {VN2}: NUP13388 H2BU163 TGFB262 DUSP1054 H3-3A50 WNT3A47 ARF146 PARP141 MIR362038 PSEN236 (50 more . . .) DISP12 MIR2151 MIR194-11 DNAH141 CDC42BPA1 1q43\u2013q44 OMIM: 612337 Names: Mental retardation, autosomal dominant 22; MRD22; chromosome 1q43\u2013q44 deletion syndrome (included); chromosome 1qter deletion syndrome (included) {VN2}: AKT3169 RYR274 ACTN269 CHRM342 MTR38 FH31 ADSS230 EXO126 RGS716 KMO15 (68 more . . .) FMN21 (Implicated Genes from Microarray Studies) (Multiple incl. RERE, SPEN) \u2020\u2021 (Multiple incl. RBM8A \u2020\u2021, GJAS \u2020) (Multiple incl. DISP1, HPE10, LEFTY1, LEFTY2, WDR26, TSEN2, BPNT1) \u2020\u2021 (AKT3, ZBTB18) \u2021 Reported Effects on Speech Delayed [9] or absent speech Delayed [10] or Impaired [11] speech Apraxia [12] Delayed, impaired, or absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 2 deletions 2p16.1\u2013p15 OMIM: 612513; Cytogenetic location: 2p16.1\u2013p15 Genomic coordinates (GRCh38): 2:54,700,000\u2013 63,900,000 Names: Chromosome 2p16.1\u2013p15 deletion syndrome {VN2}: RPS27A293 XPO156 UGP233 MDH127 REL23 CCT414 RTN413 B3GNT212 VRK210 USP347 (7 more . . .) OTX11 CCDC88A1 2p21 OMIM: 606407; Cytogenetic location: 2p21 Genomic coordinates (GRCh38): 2:41,500,000\u2013 47,500,000 Names: Hypotonia\u2013cystinuria syndrome; cystinuria with mitochondrial disease; homozygous 2p21 deletion syndrome {VN2}: CALM2234 PRKCE73 SLC3A136 HAAO22 ATP6V1E219 ABCG518 MSH217 ABCG817 EPAS116 COX7A2L15 (14 more . . .) SIX31 EML41 2q23.1 OMIM: 156200 Names: Mental retardation, autosomal dominant 1; MRD1; chromosome 2q23.1 deletion syndrome {VN2}: ORC429 KIF5C2 2q32\u2013q33 (SATB2) \u2021(HOXD cluster and regulatory elements, COL3A1 COL5A2, GTF3C3, CASP8, CASP10) \u2021\u2021 OMIM: 612313 Names: Glass syndrome; GLASS; chromosome 2q32\u2013q33 deletion syndrome; SATB2-associated syndrome {VN2}: CREB1203 STAT1130 CASP8103 NUP3579 ITGAV64 CD2860 SUMO152 AOX150 FZD543 FZD737 (52 more . . .) TMEFF21 KLF71 HSPE11 DUSP191 DNAH71 (HDAC4) \u2021 2q37.3 OMIM: 600430 (2q37); Cytogenetic location: 2q37 Genomic coordinates (GRCh38): 2:236,400,000\u2013 242,193,529 Names: Chromosome 2q37 deletion syndrome, brachydactyly\u2013intellectual disability syndrome; Albright hereditary osteodystrophy-like syndrome Type 3 {VN2}: HDAC433 GPC127 AGXT25 COL6A319 ACKR314 NEU413 NDUFA1012 PRLH11 PER211 DTYMK11 (28 more . . .) TWIST21 ILKAP1 Chromosome 3 deletions 3p13 OMIM: 613670 Names: Mental retardation with language impairment with or without autistic features {VN2}: MITF19 PROK28 PPP4R25 GPR275 EIF4E35 FOXP13 GXYLT22 RYBP1 3q13.31 OMIM: 615433; Cytogenetic location: 3q13.31 Genomic coordinates (GRCh38): 3:113,700,000\u2013 117,600,000 Names: Chromosome 3q13.31 deletion syndrome {VN2}: DRD322 ATP6V1A22 GAP436 QTRT23 LSAMP3 3q29 OMIM: 609425; Cytogenetic location: 3q29 Genomic coordinates (GRCh38): 3:192,600,000\u2013 198,295,559 Names: Chromosome 3q29 deletion syndrome; microdeletion 3q29 syndrome; 3qter deletion syn- drome {VN2}: PAK274 DLG171 NCBP253 HES139 RPL35A22 TFRC21 RNF16818 BDH117 PCYT1A15 MUC2013 (14 more . . .) FBXO451 (Implicated Genes from Microarray Studies) (Multiple incl. BCL11A) \u2020\u2021 (Multiple incl. SLC3A1, PREPL) (MBD5) \u2021 (FOXP1) \u2020\u2021 (DRD3, ZBTB20 \u2021, GAP43, LSAMP) \u2020\u2021 (Multiple incl. PAK2, DLG1) \u2020\u2021 21 of 33 Reported Effects on Speech Dysarthria, apraxia, or im- paired speech [13] Apraxia or idiosyncratic speech [14] Delayed or impaired speech Absent speech Impaired speech [15] Delayed, idiosyncratic, and impaired speech and dysarthria (all severe), apraxia [16] Impaired [17] or absent speech Delayed speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 4 deletions 4p16.3 OMIM: 194190; Cytogenetic location: 4p16.3 Genomic coordinates (GRCh38): 4:0\u20134,500,000 Names: Wolf\u2013Hirschhorn syndrome; Pitt\u2013Rogers\u2013Danks syndrome; Pitt syndrome; Wittwer syn- drome; Dillan 4p syndrome {VN1} CTBP125 {VN2}: FGFR3109 TNIP232 NELFA27 MIR94326 CTBP125 ADRA2C22 NSD219 GRK415 DGKQ14 PDE6B13 HAUS313 SLC26A112 SLBP12 ATP5ME12 RNF411 CPLX111 RGS1210 (27 more . . .) ZFYVE281 PCGF31 NSG11 MXD41 ABCA11P1 4q21 OMIM: 613509; Cytogenetic location: 4q21 Genomic coordinates (GRCh38): 4:86,000,000\u2013 87,100,000 Names: Chromosome 4q21 deletion syndrome {VN2}: MAPK10122 FGF5118 NUP5479 PAQR347 PRKG227 CXCL1022 CXCL918 ABRAXAS118 SEC31A16 CXCL1116 (31 more . . .) SHROOM31 SEPTIN111 HNRNPDL1 G3BP21 BMP2K1 AFF11 Chromosome 5 deletions 5p (5p15.2 and/or (5p15.3 or 5p15.33)) OMIM: 123450 Names: Chromosome 5p deletion syndrome; cri-du-chat syndrome; cat cry syndrome; Lejeune syndrome; 5p monosomy; partial monosomy 5 {VN2}: ADCY2116 SLC6A373 SDHA37 TERT24 TRIO23 MTRR19 LPCAT115 CEP7215 SRD5A114 SLC9A313 (27 more . . .) OTULINL1 CTNND21 CLPTM1L1 (MEF2C) \u2021 5q14.3 OMIM: 612881 (distal version 5q14.3\u2013q15); Cytogenetic location: 5q14.3\u2013q15 Genomic coordinates (GRCh38): 5:83,500,000\u201398,900,000 Names: Distal chromosome 5q14.3 deletion syndrome; periventricular heterotopia associated with chromosome 5q deletion; periventricular nodular heterotopia 5; PVNH5 {VN2}: RASA189 CCNH74 MEF2C70 POLR3G17 COX7C15 MIR9-27 EDIL33 5q33.1 OMIM: 153550 Names: Chromosome 5q deletion syndrome; 5q syndrome; refractory macrocytic anemia due to 5q deletion; MAR {VN2}: RPS1429 GPX318 DCTN413 SPARC12 SLC36A112 NMUR211 CD7410 NDST19 GM2A8 TNIP16 (7 more . . .) SYNPO1 IRGM1 5q35.3 OMIM: 117550 Names: Sotos syndrome 1; Sotos1; Nevo syndrome; cerebral gigantism, Nevo type; chromosome 5q35 deletion syndrome {VN1} NSD18 {VN2}: MAPK9167 LTC4S53 F1233 SQSTM130 MAML129 RACK125 FLT423 CANX22 GRK620 GRM616 (37 more ."}, {"question": " What is the syndrome associated with Chromosome 5 deletions at 5p and some member chainlink genes?,answer: The syndrome associated is Chromosome 5p deletion syndrome and some member chainlink genes are ADCY2116, SLC6A373, SDHA37, etc.", "ref_chunk": "in the voicechains found for the syndrome are shown in bold font. Second column: The second column in this table lists the corresponding speech characteristics, with references. Where no reference is cited, the information is found in the OMIM record for the syndrome (where possible, OMIM references are used for brevity). Table A1. Chainlink genes for level-1 and level-2 voice chain ensembles for 76 chromosomal mi- crodeletion syndromes. Each chain forms a link from the gene shown to the ACC biological pathway of FOXP2 and has been automatically derived. The total number of pathways that each gene in\ufb02u- ences independently is shown as a subscript to its name. Observed phenotypic effects on speech are given in the last column. When references are not cited, the information re\ufb02ects that in the OMIM records for the syndrome. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 1 deletions 1p36 OMIM: 607872; Cytogenetic location: 1p36; Genomic coordinates (GRCh38): 1:23,600,000\u2013 27,600,000 Names: Chromosome 1p36 deletion sydrome; monosomy 1p36 syndrome {VN1} ARID1A10 {VN2}: PIK3CD168 MTOR146 GNB1140 CDC42140 CASP9108 RPS6KA193 PRKCZ75 CNKSR157 SFN55 DVL148 (216 more . . .) SSU721 RBP71 PLEKHN11 PLEKHM21 PEX101 NBL11 MTCO3P121 MMP23B1 MMP23A1 HSPB71 HMGN21 GPR31 EXOSC101 DISP31 CROCCP21 CAMTA11 AHDC11 ACAP31 1q21.1\u2013q21.2 OMIM: 612474/274000, Cytogenetic location: 1q21.1 Genomic coordinates (GRCh38): 1:143,200,000\u2013147,500,000 Names: Thrombocytopenia with absent radius (TAR) syndrome (OMIM 274000) {VN2}: H4C1467 H4C1566 H2BC2163 PRKAB257 H3C1556 H3C1456 H3C1356 H2AC2053 H2AC1953 H2AC1853 (31 more . . .) 1q41\u2013q42 OMIM: 612530; Cytogenetic location: 1q41\u2013q42 Genomic coordinates (GRCh38): 1:214,400,000\u2013 236,400,000 Names: Chromosome 1q41\u2013q42 deletion syndrome; holoprosencephaly 10; HPE10 {VN2}: NUP13388 H2BU163 TGFB262 DUSP1054 H3-3A50 WNT3A47 ARF146 PARP141 MIR362038 PSEN236 (50 more . . .) DISP12 MIR2151 MIR194-11 DNAH141 CDC42BPA1 1q43\u2013q44 OMIM: 612337 Names: Mental retardation, autosomal dominant 22; MRD22; chromosome 1q43\u2013q44 deletion syndrome (included); chromosome 1qter deletion syndrome (included) {VN2}: AKT3169 RYR274 ACTN269 CHRM342 MTR38 FH31 ADSS230 EXO126 RGS716 KMO15 (68 more . . .) FMN21 (Implicated Genes from Microarray Studies) (Multiple incl. RERE, SPEN) \u2020\u2021 (Multiple incl. RBM8A \u2020\u2021, GJAS \u2020) (Multiple incl. DISP1, HPE10, LEFTY1, LEFTY2, WDR26, TSEN2, BPNT1) \u2020\u2021 (AKT3, ZBTB18) \u2021 Reported Effects on Speech Delayed [9] or absent speech Delayed [10] or Impaired [11] speech Apraxia [12] Delayed, impaired, or absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 2 deletions 2p16.1\u2013p15 OMIM: 612513; Cytogenetic location: 2p16.1\u2013p15 Genomic coordinates (GRCh38): 2:54,700,000\u2013 63,900,000 Names: Chromosome 2p16.1\u2013p15 deletion syndrome {VN2}: RPS27A293 XPO156 UGP233 MDH127 REL23 CCT414 RTN413 B3GNT212 VRK210 USP347 (7 more . . .) OTX11 CCDC88A1 2p21 OMIM: 606407; Cytogenetic location: 2p21 Genomic coordinates (GRCh38): 2:41,500,000\u2013 47,500,000 Names: Hypotonia\u2013cystinuria syndrome; cystinuria with mitochondrial disease; homozygous 2p21 deletion syndrome {VN2}: CALM2234 PRKCE73 SLC3A136 HAAO22 ATP6V1E219 ABCG518 MSH217 ABCG817 EPAS116 COX7A2L15 (14 more . . .) SIX31 EML41 2q23.1 OMIM: 156200 Names: Mental retardation, autosomal dominant 1; MRD1; chromosome 2q23.1 deletion syndrome {VN2}: ORC429 KIF5C2 2q32\u2013q33 (SATB2) \u2021(HOXD cluster and regulatory elements, COL3A1 COL5A2, GTF3C3, CASP8, CASP10) \u2021\u2021 OMIM: 612313 Names: Glass syndrome; GLASS; chromosome 2q32\u2013q33 deletion syndrome; SATB2-associated syndrome {VN2}: CREB1203 STAT1130 CASP8103 NUP3579 ITGAV64 CD2860 SUMO152 AOX150 FZD543 FZD737 (52 more . . .) TMEFF21 KLF71 HSPE11 DUSP191 DNAH71 (HDAC4) \u2021 2q37.3 OMIM: 600430 (2q37); Cytogenetic location: 2q37 Genomic coordinates (GRCh38): 2:236,400,000\u2013 242,193,529 Names: Chromosome 2q37 deletion syndrome, brachydactyly\u2013intellectual disability syndrome; Albright hereditary osteodystrophy-like syndrome Type 3 {VN2}: HDAC433 GPC127 AGXT25 COL6A319 ACKR314 NEU413 NDUFA1012 PRLH11 PER211 DTYMK11 (28 more . . .) TWIST21 ILKAP1 Chromosome 3 deletions 3p13 OMIM: 613670 Names: Mental retardation with language impairment with or without autistic features {VN2}: MITF19 PROK28 PPP4R25 GPR275 EIF4E35 FOXP13 GXYLT22 RYBP1 3q13.31 OMIM: 615433; Cytogenetic location: 3q13.31 Genomic coordinates (GRCh38): 3:113,700,000\u2013 117,600,000 Names: Chromosome 3q13.31 deletion syndrome {VN2}: DRD322 ATP6V1A22 GAP436 QTRT23 LSAMP3 3q29 OMIM: 609425; Cytogenetic location: 3q29 Genomic coordinates (GRCh38): 3:192,600,000\u2013 198,295,559 Names: Chromosome 3q29 deletion syndrome; microdeletion 3q29 syndrome; 3qter deletion syn- drome {VN2}: PAK274 DLG171 NCBP253 HES139 RPL35A22 TFRC21 RNF16818 BDH117 PCYT1A15 MUC2013 (14 more . . .) FBXO451 (Implicated Genes from Microarray Studies) (Multiple incl. BCL11A) \u2020\u2021 (Multiple incl. SLC3A1, PREPL) (MBD5) \u2021 (FOXP1) \u2020\u2021 (DRD3, ZBTB20 \u2021, GAP43, LSAMP) \u2020\u2021 (Multiple incl. PAK2, DLG1) \u2020\u2021 21 of 33 Reported Effects on Speech Dysarthria, apraxia, or im- paired speech [13] Apraxia or idiosyncratic speech [14] Delayed or impaired speech Absent speech Impaired speech [15] Delayed, idiosyncratic, and impaired speech and dysarthria (all severe), apraxia [16] Impaired [17] or absent speech Delayed speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 4 deletions 4p16.3 OMIM: 194190; Cytogenetic location: 4p16.3 Genomic coordinates (GRCh38): 4:0\u20134,500,000 Names: Wolf\u2013Hirschhorn syndrome; Pitt\u2013Rogers\u2013Danks syndrome; Pitt syndrome; Wittwer syn- drome; Dillan 4p syndrome {VN1} CTBP125 {VN2}: FGFR3109 TNIP232 NELFA27 MIR94326 CTBP125 ADRA2C22 NSD219 GRK415 DGKQ14 PDE6B13 HAUS313 SLC26A112 SLBP12 ATP5ME12 RNF411 CPLX111 RGS1210 (27 more . . .) ZFYVE281 PCGF31 NSG11 MXD41 ABCA11P1 4q21 OMIM: 613509; Cytogenetic location: 4q21 Genomic coordinates (GRCh38): 4:86,000,000\u2013 87,100,000 Names: Chromosome 4q21 deletion syndrome {VN2}: MAPK10122 FGF5118 NUP5479 PAQR347 PRKG227 CXCL1022 CXCL918 ABRAXAS118 SEC31A16 CXCL1116 (31 more . . .) SHROOM31 SEPTIN111 HNRNPDL1 G3BP21 BMP2K1 AFF11 Chromosome 5 deletions 5p (5p15.2 and/or (5p15.3 or 5p15.33)) OMIM: 123450 Names: Chromosome 5p deletion syndrome; cri-du-chat syndrome; cat cry syndrome; Lejeune syndrome; 5p monosomy; partial monosomy 5 {VN2}: ADCY2116 SLC6A373 SDHA37 TERT24 TRIO23 MTRR19 LPCAT115 CEP7215 SRD5A114 SLC9A313 (27 more . . .) OTULINL1 CTNND21 CLPTM1L1 (MEF2C) \u2021 5q14.3 OMIM: 612881 (distal version 5q14.3\u2013q15); Cytogenetic location: 5q14.3\u2013q15 Genomic coordinates (GRCh38): 5:83,500,000\u201398,900,000 Names: Distal chromosome 5q14.3 deletion syndrome; periventricular heterotopia associated with chromosome 5q deletion; periventricular nodular heterotopia 5; PVNH5 {VN2}: RASA189 CCNH74 MEF2C70 POLR3G17 COX7C15 MIR9-27 EDIL33 5q33.1 OMIM: 153550 Names: Chromosome 5q deletion syndrome; 5q syndrome; refractory macrocytic anemia due to 5q deletion; MAR {VN2}: RPS1429 GPX318 DCTN413 SPARC12 SLC36A112 NMUR211 CD7410 NDST19 GM2A8 TNIP16 (7 more . . .) SYNPO1 IRGM1 5q35.3 OMIM: 117550 Names: Sotos syndrome 1; Sotos1; Nevo syndrome; cerebral gigantism, Nevo type; chromosome 5q35 deletion syndrome {VN1} NSD18 {VN2}: MAPK9167 LTC4S53 F1233 SQSTM130 MAML129 RACK125 FLT423 CANX22 GRK620 GRM616 (37 more ."}, {"question": " What effects on speech are reported for the syndrome associated with Chromosome 5q33.1 deletions?,answer: Reported effects on speech include dysarthria, apraxia, or impaired speech.", "ref_chunk": "in the voicechains found for the syndrome are shown in bold font. Second column: The second column in this table lists the corresponding speech characteristics, with references. Where no reference is cited, the information is found in the OMIM record for the syndrome (where possible, OMIM references are used for brevity). Table A1. Chainlink genes for level-1 and level-2 voice chain ensembles for 76 chromosomal mi- crodeletion syndromes. Each chain forms a link from the gene shown to the ACC biological pathway of FOXP2 and has been automatically derived. The total number of pathways that each gene in\ufb02u- ences independently is shown as a subscript to its name. Observed phenotypic effects on speech are given in the last column. When references are not cited, the information re\ufb02ects that in the OMIM records for the syndrome. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 1 deletions 1p36 OMIM: 607872; Cytogenetic location: 1p36; Genomic coordinates (GRCh38): 1:23,600,000\u2013 27,600,000 Names: Chromosome 1p36 deletion sydrome; monosomy 1p36 syndrome {VN1} ARID1A10 {VN2}: PIK3CD168 MTOR146 GNB1140 CDC42140 CASP9108 RPS6KA193 PRKCZ75 CNKSR157 SFN55 DVL148 (216 more . . .) SSU721 RBP71 PLEKHN11 PLEKHM21 PEX101 NBL11 MTCO3P121 MMP23B1 MMP23A1 HSPB71 HMGN21 GPR31 EXOSC101 DISP31 CROCCP21 CAMTA11 AHDC11 ACAP31 1q21.1\u2013q21.2 OMIM: 612474/274000, Cytogenetic location: 1q21.1 Genomic coordinates (GRCh38): 1:143,200,000\u2013147,500,000 Names: Thrombocytopenia with absent radius (TAR) syndrome (OMIM 274000) {VN2}: H4C1467 H4C1566 H2BC2163 PRKAB257 H3C1556 H3C1456 H3C1356 H2AC2053 H2AC1953 H2AC1853 (31 more . . .) 1q41\u2013q42 OMIM: 612530; Cytogenetic location: 1q41\u2013q42 Genomic coordinates (GRCh38): 1:214,400,000\u2013 236,400,000 Names: Chromosome 1q41\u2013q42 deletion syndrome; holoprosencephaly 10; HPE10 {VN2}: NUP13388 H2BU163 TGFB262 DUSP1054 H3-3A50 WNT3A47 ARF146 PARP141 MIR362038 PSEN236 (50 more . . .) DISP12 MIR2151 MIR194-11 DNAH141 CDC42BPA1 1q43\u2013q44 OMIM: 612337 Names: Mental retardation, autosomal dominant 22; MRD22; chromosome 1q43\u2013q44 deletion syndrome (included); chromosome 1qter deletion syndrome (included) {VN2}: AKT3169 RYR274 ACTN269 CHRM342 MTR38 FH31 ADSS230 EXO126 RGS716 KMO15 (68 more . . .) FMN21 (Implicated Genes from Microarray Studies) (Multiple incl. RERE, SPEN) \u2020\u2021 (Multiple incl. RBM8A \u2020\u2021, GJAS \u2020) (Multiple incl. DISP1, HPE10, LEFTY1, LEFTY2, WDR26, TSEN2, BPNT1) \u2020\u2021 (AKT3, ZBTB18) \u2021 Reported Effects on Speech Delayed [9] or absent speech Delayed [10] or Impaired [11] speech Apraxia [12] Delayed, impaired, or absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 2 deletions 2p16.1\u2013p15 OMIM: 612513; Cytogenetic location: 2p16.1\u2013p15 Genomic coordinates (GRCh38): 2:54,700,000\u2013 63,900,000 Names: Chromosome 2p16.1\u2013p15 deletion syndrome {VN2}: RPS27A293 XPO156 UGP233 MDH127 REL23 CCT414 RTN413 B3GNT212 VRK210 USP347 (7 more . . .) OTX11 CCDC88A1 2p21 OMIM: 606407; Cytogenetic location: 2p21 Genomic coordinates (GRCh38): 2:41,500,000\u2013 47,500,000 Names: Hypotonia\u2013cystinuria syndrome; cystinuria with mitochondrial disease; homozygous 2p21 deletion syndrome {VN2}: CALM2234 PRKCE73 SLC3A136 HAAO22 ATP6V1E219 ABCG518 MSH217 ABCG817 EPAS116 COX7A2L15 (14 more . . .) SIX31 EML41 2q23.1 OMIM: 156200 Names: Mental retardation, autosomal dominant 1; MRD1; chromosome 2q23.1 deletion syndrome {VN2}: ORC429 KIF5C2 2q32\u2013q33 (SATB2) \u2021(HOXD cluster and regulatory elements, COL3A1 COL5A2, GTF3C3, CASP8, CASP10) \u2021\u2021 OMIM: 612313 Names: Glass syndrome; GLASS; chromosome 2q32\u2013q33 deletion syndrome; SATB2-associated syndrome {VN2}: CREB1203 STAT1130 CASP8103 NUP3579 ITGAV64 CD2860 SUMO152 AOX150 FZD543 FZD737 (52 more . . .) TMEFF21 KLF71 HSPE11 DUSP191 DNAH71 (HDAC4) \u2021 2q37.3 OMIM: 600430 (2q37); Cytogenetic location: 2q37 Genomic coordinates (GRCh38): 2:236,400,000\u2013 242,193,529 Names: Chromosome 2q37 deletion syndrome, brachydactyly\u2013intellectual disability syndrome; Albright hereditary osteodystrophy-like syndrome Type 3 {VN2}: HDAC433 GPC127 AGXT25 COL6A319 ACKR314 NEU413 NDUFA1012 PRLH11 PER211 DTYMK11 (28 more . . .) TWIST21 ILKAP1 Chromosome 3 deletions 3p13 OMIM: 613670 Names: Mental retardation with language impairment with or without autistic features {VN2}: MITF19 PROK28 PPP4R25 GPR275 EIF4E35 FOXP13 GXYLT22 RYBP1 3q13.31 OMIM: 615433; Cytogenetic location: 3q13.31 Genomic coordinates (GRCh38): 3:113,700,000\u2013 117,600,000 Names: Chromosome 3q13.31 deletion syndrome {VN2}: DRD322 ATP6V1A22 GAP436 QTRT23 LSAMP3 3q29 OMIM: 609425; Cytogenetic location: 3q29 Genomic coordinates (GRCh38): 3:192,600,000\u2013 198,295,559 Names: Chromosome 3q29 deletion syndrome; microdeletion 3q29 syndrome; 3qter deletion syn- drome {VN2}: PAK274 DLG171 NCBP253 HES139 RPL35A22 TFRC21 RNF16818 BDH117 PCYT1A15 MUC2013 (14 more . . .) FBXO451 (Implicated Genes from Microarray Studies) (Multiple incl. BCL11A) \u2020\u2021 (Multiple incl. SLC3A1, PREPL) (MBD5) \u2021 (FOXP1) \u2020\u2021 (DRD3, ZBTB20 \u2021, GAP43, LSAMP) \u2020\u2021 (Multiple incl. PAK2, DLG1) \u2020\u2021 21 of 33 Reported Effects on Speech Dysarthria, apraxia, or im- paired speech [13] Apraxia or idiosyncratic speech [14] Delayed or impaired speech Absent speech Impaired speech [15] Delayed, idiosyncratic, and impaired speech and dysarthria (all severe), apraxia [16] Impaired [17] or absent speech Delayed speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 4 deletions 4p16.3 OMIM: 194190; Cytogenetic location: 4p16.3 Genomic coordinates (GRCh38): 4:0\u20134,500,000 Names: Wolf\u2013Hirschhorn syndrome; Pitt\u2013Rogers\u2013Danks syndrome; Pitt syndrome; Wittwer syn- drome; Dillan 4p syndrome {VN1} CTBP125 {VN2}: FGFR3109 TNIP232 NELFA27 MIR94326 CTBP125 ADRA2C22 NSD219 GRK415 DGKQ14 PDE6B13 HAUS313 SLC26A112 SLBP12 ATP5ME12 RNF411 CPLX111 RGS1210 (27 more . . .) ZFYVE281 PCGF31 NSG11 MXD41 ABCA11P1 4q21 OMIM: 613509; Cytogenetic location: 4q21 Genomic coordinates (GRCh38): 4:86,000,000\u2013 87,100,000 Names: Chromosome 4q21 deletion syndrome {VN2}: MAPK10122 FGF5118 NUP5479 PAQR347 PRKG227 CXCL1022 CXCL918 ABRAXAS118 SEC31A16 CXCL1116 (31 more . . .) SHROOM31 SEPTIN111 HNRNPDL1 G3BP21 BMP2K1 AFF11 Chromosome 5 deletions 5p (5p15.2 and/or (5p15.3 or 5p15.33)) OMIM: 123450 Names: Chromosome 5p deletion syndrome; cri-du-chat syndrome; cat cry syndrome; Lejeune syndrome; 5p monosomy; partial monosomy 5 {VN2}: ADCY2116 SLC6A373 SDHA37 TERT24 TRIO23 MTRR19 LPCAT115 CEP7215 SRD5A114 SLC9A313 (27 more . . .) OTULINL1 CTNND21 CLPTM1L1 (MEF2C) \u2021 5q14.3 OMIM: 612881 (distal version 5q14.3\u2013q15); Cytogenetic location: 5q14.3\u2013q15 Genomic coordinates (GRCh38): 5:83,500,000\u201398,900,000 Names: Distal chromosome 5q14.3 deletion syndrome; periventricular heterotopia associated with chromosome 5q deletion; periventricular nodular heterotopia 5; PVNH5 {VN2}: RASA189 CCNH74 MEF2C70 POLR3G17 COX7C15 MIR9-27 EDIL33 5q33.1 OMIM: 153550 Names: Chromosome 5q deletion syndrome; 5q syndrome; refractory macrocytic anemia due to 5q deletion; MAR {VN2}: RPS1429 GPX318 DCTN413 SPARC12 SLC36A112 NMUR211 CD7410 NDST19 GM2A8 TNIP16 (7 more . . .) SYNPO1 IRGM1 5q35.3 OMIM: 117550 Names: Sotos syndrome 1; Sotos1; Nevo syndrome; cerebral gigantism, Nevo type; chromosome 5q35 deletion syndrome {VN1} NSD18 {VN2}: MAPK9167 LTC4S53 F1233 SQSTM130 MAML129 RACK125 FLT423 CANX22 GRK620 GRM616 (37 more ."}], "doc_text": "in the voicechains found for the syndrome are shown in bold font. Second column: The second column in this table lists the corresponding speech characteristics, with references. Where no reference is cited, the information is found in the OMIM record for the syndrome (where possible, OMIM references are used for brevity). Table A1. Chainlink genes for level-1 and level-2 voice chain ensembles for 76 chromosomal mi- crodeletion syndromes. Each chain forms a link from the gene shown to the ACC biological pathway of FOXP2 and has been automatically derived. The total number of pathways that each gene in\ufb02u- ences independently is shown as a subscript to its name. Observed phenotypic effects on speech are given in the last column. When references are not cited, the information re\ufb02ects that in the OMIM records for the syndrome. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 1 deletions 1p36 OMIM: 607872; Cytogenetic location: 1p36; Genomic coordinates (GRCh38): 1:23,600,000\u2013 27,600,000 Names: Chromosome 1p36 deletion sydrome; monosomy 1p36 syndrome {VN1} ARID1A10 {VN2}: PIK3CD168 MTOR146 GNB1140 CDC42140 CASP9108 RPS6KA193 PRKCZ75 CNKSR157 SFN55 DVL148 (216 more . . .) SSU721 RBP71 PLEKHN11 PLEKHM21 PEX101 NBL11 MTCO3P121 MMP23B1 MMP23A1 HSPB71 HMGN21 GPR31 EXOSC101 DISP31 CROCCP21 CAMTA11 AHDC11 ACAP31 1q21.1\u2013q21.2 OMIM: 612474/274000, Cytogenetic location: 1q21.1 Genomic coordinates (GRCh38): 1:143,200,000\u2013147,500,000 Names: Thrombocytopenia with absent radius (TAR) syndrome (OMIM 274000) {VN2}: H4C1467 H4C1566 H2BC2163 PRKAB257 H3C1556 H3C1456 H3C1356 H2AC2053 H2AC1953 H2AC1853 (31 more . . .) 1q41\u2013q42 OMIM: 612530; Cytogenetic location: 1q41\u2013q42 Genomic coordinates (GRCh38): 1:214,400,000\u2013 236,400,000 Names: Chromosome 1q41\u2013q42 deletion syndrome; holoprosencephaly 10; HPE10 {VN2}: NUP13388 H2BU163 TGFB262 DUSP1054 H3-3A50 WNT3A47 ARF146 PARP141 MIR362038 PSEN236 (50 more . . .) DISP12 MIR2151 MIR194-11 DNAH141 CDC42BPA1 1q43\u2013q44 OMIM: 612337 Names: Mental retardation, autosomal dominant 22; MRD22; chromosome 1q43\u2013q44 deletion syndrome (included); chromosome 1qter deletion syndrome (included) {VN2}: AKT3169 RYR274 ACTN269 CHRM342 MTR38 FH31 ADSS230 EXO126 RGS716 KMO15 (68 more . . .) FMN21 (Implicated Genes from Microarray Studies) (Multiple incl. RERE, SPEN) \u2020\u2021 (Multiple incl. RBM8A \u2020\u2021, GJAS \u2020) (Multiple incl. DISP1, HPE10, LEFTY1, LEFTY2, WDR26, TSEN2, BPNT1) \u2020\u2021 (AKT3, ZBTB18) \u2021 Reported Effects on Speech Delayed [9] or absent speech Delayed [10] or Impaired [11] speech Apraxia [12] Delayed, impaired, or absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 2 deletions 2p16.1\u2013p15 OMIM: 612513; Cytogenetic location: 2p16.1\u2013p15 Genomic coordinates (GRCh38): 2:54,700,000\u2013 63,900,000 Names: Chromosome 2p16.1\u2013p15 deletion syndrome {VN2}: RPS27A293 XPO156 UGP233 MDH127 REL23 CCT414 RTN413 B3GNT212 VRK210 USP347 (7 more . . .) OTX11 CCDC88A1 2p21 OMIM: 606407; Cytogenetic location: 2p21 Genomic coordinates (GRCh38): 2:41,500,000\u2013 47,500,000 Names: Hypotonia\u2013cystinuria syndrome; cystinuria with mitochondrial disease; homozygous 2p21 deletion syndrome {VN2}: CALM2234 PRKCE73 SLC3A136 HAAO22 ATP6V1E219 ABCG518 MSH217 ABCG817 EPAS116 COX7A2L15 (14 more . . .) SIX31 EML41 2q23.1 OMIM: 156200 Names: Mental retardation, autosomal dominant 1; MRD1; chromosome 2q23.1 deletion syndrome {VN2}: ORC429 KIF5C2 2q32\u2013q33 (SATB2) \u2021(HOXD cluster and regulatory elements, COL3A1 COL5A2, GTF3C3, CASP8, CASP10) \u2021\u2021 OMIM: 612313 Names: Glass syndrome; GLASS; chromosome 2q32\u2013q33 deletion syndrome; SATB2-associated syndrome {VN2}: CREB1203 STAT1130 CASP8103 NUP3579 ITGAV64 CD2860 SUMO152 AOX150 FZD543 FZD737 (52 more . . .) TMEFF21 KLF71 HSPE11 DUSP191 DNAH71 (HDAC4) \u2021 2q37.3 OMIM: 600430 (2q37); Cytogenetic location: 2q37 Genomic coordinates (GRCh38): 2:236,400,000\u2013 242,193,529 Names: Chromosome 2q37 deletion syndrome, brachydactyly\u2013intellectual disability syndrome; Albright hereditary osteodystrophy-like syndrome Type 3 {VN2}: HDAC433 GPC127 AGXT25 COL6A319 ACKR314 NEU413 NDUFA1012 PRLH11 PER211 DTYMK11 (28 more . . .) TWIST21 ILKAP1 Chromosome 3 deletions 3p13 OMIM: 613670 Names: Mental retardation with language impairment with or without autistic features {VN2}: MITF19 PROK28 PPP4R25 GPR275 EIF4E35 FOXP13 GXYLT22 RYBP1 3q13.31 OMIM: 615433; Cytogenetic location: 3q13.31 Genomic coordinates (GRCh38): 3:113,700,000\u2013 117,600,000 Names: Chromosome 3q13.31 deletion syndrome {VN2}: DRD322 ATP6V1A22 GAP436 QTRT23 LSAMP3 3q29 OMIM: 609425; Cytogenetic location: 3q29 Genomic coordinates (GRCh38): 3:192,600,000\u2013 198,295,559 Names: Chromosome 3q29 deletion syndrome; microdeletion 3q29 syndrome; 3qter deletion syn- drome {VN2}: PAK274 DLG171 NCBP253 HES139 RPL35A22 TFRC21 RNF16818 BDH117 PCYT1A15 MUC2013 (14 more . . .) FBXO451 (Implicated Genes from Microarray Studies) (Multiple incl. BCL11A) \u2020\u2021 (Multiple incl. SLC3A1, PREPL) (MBD5) \u2021 (FOXP1) \u2020\u2021 (DRD3, ZBTB20 \u2021, GAP43, LSAMP) \u2020\u2021 (Multiple incl. PAK2, DLG1) \u2020\u2021 21 of 33 Reported Effects on Speech Dysarthria, apraxia, or im- paired speech [13] Apraxia or idiosyncratic speech [14] Delayed or impaired speech Absent speech Impaired speech [15] Delayed, idiosyncratic, and impaired speech and dysarthria (all severe), apraxia [16] Impaired [17] or absent speech Delayed speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 4 deletions 4p16.3 OMIM: 194190; Cytogenetic location: 4p16.3 Genomic coordinates (GRCh38): 4:0\u20134,500,000 Names: Wolf\u2013Hirschhorn syndrome; Pitt\u2013Rogers\u2013Danks syndrome; Pitt syndrome; Wittwer syn- drome; Dillan 4p syndrome {VN1} CTBP125 {VN2}: FGFR3109 TNIP232 NELFA27 MIR94326 CTBP125 ADRA2C22 NSD219 GRK415 DGKQ14 PDE6B13 HAUS313 SLC26A112 SLBP12 ATP5ME12 RNF411 CPLX111 RGS1210 (27 more . . .) ZFYVE281 PCGF31 NSG11 MXD41 ABCA11P1 4q21 OMIM: 613509; Cytogenetic location: 4q21 Genomic coordinates (GRCh38): 4:86,000,000\u2013 87,100,000 Names: Chromosome 4q21 deletion syndrome {VN2}: MAPK10122 FGF5118 NUP5479 PAQR347 PRKG227 CXCL1022 CXCL918 ABRAXAS118 SEC31A16 CXCL1116 (31 more . . .) SHROOM31 SEPTIN111 HNRNPDL1 G3BP21 BMP2K1 AFF11 Chromosome 5 deletions 5p (5p15.2 and/or (5p15.3 or 5p15.33)) OMIM: 123450 Names: Chromosome 5p deletion syndrome; cri-du-chat syndrome; cat cry syndrome; Lejeune syndrome; 5p monosomy; partial monosomy 5 {VN2}: ADCY2116 SLC6A373 SDHA37 TERT24 TRIO23 MTRR19 LPCAT115 CEP7215 SRD5A114 SLC9A313 (27 more . . .) OTULINL1 CTNND21 CLPTM1L1 (MEF2C) \u2021 5q14.3 OMIM: 612881 (distal version 5q14.3\u2013q15); Cytogenetic location: 5q14.3\u2013q15 Genomic coordinates (GRCh38): 5:83,500,000\u201398,900,000 Names: Distal chromosome 5q14.3 deletion syndrome; periventricular heterotopia associated with chromosome 5q deletion; periventricular nodular heterotopia 5; PVNH5 {VN2}: RASA189 CCNH74 MEF2C70 POLR3G17 COX7C15 MIR9-27 EDIL33 5q33.1 OMIM: 153550 Names: Chromosome 5q deletion syndrome; 5q syndrome; refractory macrocytic anemia due to 5q deletion; MAR {VN2}: RPS1429 GPX318 DCTN413 SPARC12 SLC36A112 NMUR211 CD7410 NDST19 GM2A8 TNIP16 (7 more . . .) SYNPO1 IRGM1 5q35.3 OMIM: 117550 Names: Sotos syndrome 1; Sotos1; Nevo syndrome; cerebral gigantism, Nevo type; chromosome 5q35 deletion syndrome {VN1} NSD18 {VN2}: MAPK9167 LTC4S53 F1233 SQSTM130 MAML129 RACK125 FLT423 CANX22 GRK620 GRM616 (37 more ."}